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Over the past few decades, nanotechnology has gained increasing attention, which is 
due to its various fields of applications such as medicine, molecular diagnostics 
electronics, energy, and environment (1-3). Their potential application as drug delivery, 
protein- and peptide delivery has become the focus of pharmaceutical research interests. 
It is a promising tool for overcoming the formulation problems of drugs of undesirable 
physicochemical properties (4, 5). 
Multifarious nanosized drug delivery systems have been developed, but the 
significance of the solid lipid matrix-based formulations, inorganic nanoparticles, and the 
polymeric nanocarrier and nanofibers are the most decisive ones (6). Incorporation of 
drugs in nanosized systems offer several advantages, for example, the therapeutic efficacy 
can promote, the drug dissolution and consequently, the bioavailability can improve (6). 
Among the polymer-based nanocarriers, the formulation of nanofiber systems has 
become a very intensively researched field in recent years. Therefore, my thesis focuses 
on approaches based on the applications of the fibrous materials as drug delivery carriers 
(7, 8).  
Several techniques exist for preparing fibrous materials. Rotary spinning, melt 
spinning and electrospinning are the most commonly used techniques for fabrication 
fibers of a monolithic structure. The latter method is able to form a fiber of core-shell 
structure by using a special coaxial or triaxial emitter (9). 
 
1.1.  Electrospinning technique 
Electrospinning is a relatively simple, well-established, intensively investigated, and 
economical fiber fabrication technique, which is able to form continuous fibers in the 
submicron range under atmospheric pressure and without the use of high temperature, 
making the formulation of sensitive drugs possible.  
 
Figure 1 Construction of a lab-scale electrospinning device 
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 Figure 1 illustrates the setup of a lab-scale electrospinning device schematically. It 
has three major parts: the high-voltage power supply, the spinneret (emitter, metallic-
needle) and the grounded collector. The emitter is connected to the syringe through a 
Teflon tube. The prepared precursor (viscous polymer solution or melt) is transferred into 
a syringe, which is placed in a syringe pump that provides the continuous and controlled 
flow rate. Fabrication of fibrous materials is carried out by applying high-voltage and is 
based on the uniaxial stretching of the viscoelastic jet derived from the precursor system 
(10). During the process, the solvent or solvent mixture evaporates, leaving behind a solid 
fibrous mesh on the collector. Electrospinning is a continuous method, which makes it 
suitable for high-volume production. Its popularity is due to the fact that it is a well 
controllable method for preparing matrices of nano- and micrometer-sizes (11-14). The 
polymeric fibrous mesh can be prepared from a melt and also from solution precursor 
systems using an electric field (15-17). The fiber diameters can be controlled well by the 
process (flow rate, emitter to collector distance, applied voltage) (11, 18, 19) and 
environmental parameters (temperature, relative humidity) (20, 21, 18) and also by the 
spinnable precursor physicochemical properties (e.g. molecular weight of the polymer, 
concentration, surface tension, conductivity, rheological properties) (11, 22, 23, 18, 24-
26). The possibility of fine-tailoring of the fiber characteristics through the optimization 
of process parameters has been discussed in several research papers (9). The major 
challenge is associated with the production rate, but its scale-up possibility has been 
investigated. Despite several solutions and implementations, it is still in its infancy, but 
due to the improvements, its industrial application is very promising (27-30). 
 
1.2. Advantages and the related applications of micro- and nanofibrous systems 
There is a wide range of properties of the fibrous materials that can be used in a broad 
range of biomedical and pharmaceutical applications (9). The unique properties of the 
random mesh of the nanofibers - high porosity, and the increased surface area to volume 
ratio - make them attractive as drug delivery vehicles (31). Due to their unique structure, 
the multifunction property, together with different drugs, can be embedded into 
nanofibers, and fibers can be prepared from a wide variety of polymers thus modifying 
the function-related characteristics which are commonly used in tissue regenerations and 
wound healing (32-35). The latter is based on the features and morphology of the 
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nanofibrous scaffolds that are very similar to the extracellular matrix, which has a crucial 
role in wound healing (36). Due to the this structural similarity, the fibrous scaffolds can 
stimulate cell proliferation and could help the wound healing process (37).  
Besides the widespread biomedical applications of the nano- and microfibrous 
materials, their pharmaceutical applicability has become an intensively researched field. 
It has a particular role in the formulation of solid dispersions of drugs with poor water 
solubility. Solid dispersions are multicomponent solid products, where the active 
ingredient is embedded into an inert matrix, whose solubility is remarkably improved due 
to its more favorable wettability and fine particle-size distribution. The grouping of these 
systems is illustrated in Figure 2. 
 
Figure 2 Grouping of solid dispersions (38) 
 
In pharmaceutical applications, drugs and biologics are usually embedded into a polymer 
matrix. In the case of poorly water-soluble active ingredients, hydrophilic polymers are 
the most commonly used matrix. A further advantage of these systems is that with a 
rational choice of the polymer, the drug release kinetics can be designed to suit therapeutic 
requirements. The possibilities offered by electrospinning are based on the fact that as a 
result of the fiber fabrication process, the active pharmaceutical ingredients (APIs) can 
be embedded into the polymeric carrier in an amorphous state; and the amorphous 
materials’ energy levels, which are higher than those of crystalline ones, may result in an 
enhanced apparent aqueous solubility and dissolution rate, and consequently, in increased 
bioavailability. It should be noted that in addition to amorphous drugs, crystalline APIs 
and biological materials can also be advantageously embedded in nanofibers (9). 
 
1.3. Excipients modifying the drug-loaded fiber characteristics 
There some other approaches in addition to the amorphization; for example, solubility 
can also be enhanced by using solubilizing agents. The use of surfactants is also providing 
DOI:10.14753/SE.2020.2446
7 
a solution for solubilizing lipophilic drugs. Polysorbate (PS) is a universal, non-ionic 
surfactant, which is widely used in the development of pharmaceutical formulation, as it 
is capable of improving the aqueous solubility of APIs and also acts as a permeability 
enhancer (39).  
Very popular, but not universal solubilizers are cyclodextrins (CDs) and their 
derivatives (40, 41). CDs are cyclic oligosaccharides composed of glucopyranose units. 
Due to their unique truncated cone structure, hydrophilic exterior surface, and a nonpolar 
interior cavity (40), they provide drug-complexes of improved solubility properties. As 
cyclic host molecules with good water-soluble property, they can form inclusion 
complexes with nonpolar drugs of appropriate size, but besides that, formation of external 
adducts may also occur. As a result of the complex formation, the physicochemical 
properties of the drug can be modified. CDs can increase the aqueous solubility of the 
drug, promote the permeation and absorption of the API across biological membranes, 
and consequently, improve its bioavailability. They can enhance the physicochemical 
stability of the drugs via specific, non-covalent bond formations (40, 42). For the fiber 
formation by electrospinning, the use of uncharged CD derivatives are preferred (43-47), 
but electrospinning from the charged sulphobutyl-ether-β-CD containing precursor 
solution has already been described (48). Furthermore, the discussed solubilizing agents 
can promote the electrospinning process and act as plasticizers. Thus they can modify the 
mechanical properties of the fibers and enhance the final applicability of the fibrous 
materials (49).  
 
1.4. Stability issues of amorphous materials 
The enhanced apparent aqueous solubility of amorphous materials can be backtracked 
to their short-range order structural property. Although they have thermodynamically 
metastable nature (50), these systems are at a higher energy level, which can lead to their 
spontaneous recrystallization. Their enhanced thermodynamic potential, together with the 
increased molecular mobility, causes the physical and/or chemical instability of these 
systems (51). However, the stability and the possibilities for stabilization are a decisive 
issue for pharmaceutical products, because the product must provide the specified dose 
in proper quality. Predicting stability and examining the possibilities for stabilization is 
of huge importance during the formulation process. With the formulation of amorphous 
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solid dispersions or molecularly dispersed solid solutions, enhanced apparent aqueous 
solubility can be achieved, and the stability problems can be solved (52-54). Polymer 
macromolecules are able to form strong intermolecular interactions (e.g., hydrogen 
bonds) that may also lead to higher physicochemical stability. By a combination of the 
polymers with other excipients, for example, surfactants that can act as kinetic stabilizers, 
resulting in third-generation ASDs of improved stability property. Due to the exhibited 
secondary interactions, a complex molecular structure can be formed, which can reduce 
the probability of physical state changes of the amorphous API, as a result of the 
decreased molecular mobility (55).  
Besides the embedded amorphous drug, the polymeric carriers are unstable also. Most 
of the polymers used for fiber formation are in an amorphous state, but if the polymeric 
carrier has semi-crystalline features that can promote the drug migration to the surface of 
the fiber, which can easily result in surface-crystallization (6). Aging-related processes 
can be related not only to the potential transition of the amorphous-crystalline form of the 
drug, but it can also entail the supramolecular alternations of the polymeric carrier as well. 
The long-term stability of polymer-based ASDs is determined by these two phenomena 
together, because they could affect the release characteristic and kinetics of the embedded 
drugs, which have a decisive impact on the bioavailability and therapeutic effect (51). 
Therefore, great attention should be paid to tracking the solid-state stability and 
monitoring the supramolecular changes of the drug-loaded nanofibrous mesh, since it is 
a critical point during the stability of these formulations (56). For investigating the 
complex micro- and macrostructural alterations, several techniques must be used, which 
can be classified into three groups: (i) imaging techniques, (ii) macrostructural, and (iii) 
microstructural characterization methods (56).  
In the following, two techniques are discussed in detail. One of them is solid-state 
nuclear magnetic resonance (ssNMR), which is a very sensitive method, able to verify 
the nature of the amorphous systems and reveal the plasticizing mechanism. However, 
with this characterization technique, the free volumes are remaining invisible (57-61). In 
contrast, positron annihilation lifetime spectroscopy (PALS) is a sensitive method to 
determine the size distribution of free volume holes through ortho-positronium (o-Ps) 




1.5. Pharmaceutical application possibilities of nanofibrous systems 
The nanofibrous formulations of required stability and desired function related 
properties are promising candidates for several dosage forms and pharmaceutical 
administration. A wide range of polymers can be used for solvent-based electrospinning, 
but the various polymers have different electrospinnable property. However, the low 
solubility of the drug in the fiber-forming solution limits the relative amount of drug in 
the nanofibers, and consequently the mass of the final product, as every polymer has an 
optimal concentration range where optimal fiber characteristic can be achieved. 
Therefore, the nanofiber-based formulations can be a potential product in the case of the 
API of a lower dose. The prepared nanofiber can be used as a final product, e.g., as buccal 
or sublingual sheets (66-68), wound bandage (69-72), or as intermediate product. After 
milling the fibers, an orodispersible (73) or a conventional tablet can be formed, but in 
the latter case great attention should be paid to monitoring changes in the physical state 
of the embedded drug(s), because changes may occur as a result of the milling process 
(74-77). Nanofibrous materials could be promising candidates for various administration 
routes; besides the most common per os application of the different formulations, the oral 
cavity is a possible site for the nanofiber-based controlled or fast release drug delivery 
systems for local therapy of the diseases of the oral cavity (78-80). In the case of this 
application, the most important factors are residence time and local drug concentration, 
because these influence the amount of the absorbed drug (81-83). The transmucosal routes 
offer an excellent alternative for systemic drug delivery of the APIs because of better 
patient adherence, ease of removal of the dosage form in emergencies, and good 
accessibility. That is due to the anatomic features of the mucosa: highly vascularized, rich 
in blood supply, and relatively permeable (84). However, permeation enhancers (e.g. PS, 
sodium lauryl sulfate, CDs) must be used to achieve the adequate level of bioavailability 
(85-87). Pharmaceutically luring advantages of the nanofibrous buccal formulations make 
them a very promising dosage form for diseases where the rapid onset (e.g., pain relief, 
nausea, migraine) is essential and in the case of APIs owing to the risk of potential liver 
damage. With nanofibers, the solubility related issue can be solved, whilst with the buccal 
administration route aims at the concerns associated with hepatic fist-pass metabolism 
and higher inter- and intraindividual varieties (88-94).  
DOI:10.14753/SE.2020.2446
10 
2.  OBJECTIVES 
The main objectives of my work were as follows. 
 To formulate a papaverine-HCl-loaded nanofibrous sample for further buccal 
administration. For the bases of the formulation the first generation mucoadhesive 
hydroxypropyl cellulose (HPC) was chosen, but to improve its electrospinnability 
poly(vinyl alcohol) (PVA) was added to the system.  
 To determine the best composition for the fiber fabrication by electrospinning via 
preformulation study of different HPC-PVA mass ratios. (Besides, the total polymer 
concentration was kept constant.) 
 To investigate the effect of rheological properties and intermolecular interactions 
on morphological characteristics of the fabricated sample. 
 Supramolecular characterization and physicochemical investigation of the 
samples. 
 To examine the physicochemical stability of the drug-loaded nanofibers and to 
highlight how the physical aging of the polymeric carrier and the solid-state transition of 
the embedded drug take place. 
 
 To prepare antiemetic drug (metoclopramide-HCl (MH) containing, PVA-based 
nanofibrous buccal sheets via electrospinning by using different permeability enhancer 
excipients: polysorbate 80 (PS 80) or hydroxypropyl-beta-cyclodextrin (HP-β-CD). 
 Morphological characterization of the electrospun sample. 
 To compare the mechanical features of the drug-loaded fibers containing PS 80 
or HP-β-CD. 
 Solid-state characterization of the sample with particular attention paid to the 
investigation of the physical state of the embedded drug. 
 To obtain information on the plasticizing effect of the used excipients and to 
investigate the molecular mobility of the fibrous systems. 
 To study the dissolution profile of the formulations and to obtain information on 
drug distribution. 
 To examine the stress tolerance capacity, especially the supramolecular changing 




3.  RESULTS 
3.1. Preformulation study of papaverine-HCl-loaded samples 
3.1.1. Lorentz-Lorenz analysis of the precursor solutions used for electrospinning 
Using the measured density and refractive index for precursor solutions of different 
HPC:PVA mass ratios, the Rm values, and space-filling factors were calculated. As a 
function of the PVA (as an auxiliary polymer) concentration of the precursor solutions 
(% w/w), the Rm values were plotted, and the slope of the fitted linear curve was 2.4024, 
and the linear regression accuracy value (R2) was 0.9999. The Rc values of each viscous 
solution were calculated based on the linear regression. The space-filling factor were 
0.224, 0.223, 0.223, 0.225 and 0.225 for precursor solution of HPC:PVA (m:m) of 5:5, 
6:4, 7:3, 8:2 and 9:1, respectively. So a remarkable difference between these values was 
not found. 
 
Figure 3 Lorentz-Lorenz plot values of papaverine-HCl loaded precursor solutions 
of different HPC:PVA mass ratios 
(Rm is a measured and Rc is a calculated molar refraction index) 
 
Figure 3 represents the Lorentz-Lorenz plot values of the drug-loaded precursor solutions 
as a function of their HPC:PVA mass ratio. It can be observed that with the increasing 




3.1.2. Rheological investigations of the polymer precursors  
The viscoelasticity of the precursor solutions fundamentally determines the jet 
formation and stability; thus, it is a very critical parameter for the fiber formation process.  
The storage and loss moduli were determined by oscillatory test measurements. The 
achieved moduli values were compared at different frequency values, but their ratio 
showed the same tendency; thereby, only the G”/G’ dynamic moduli ratio results relating 
to 1.995 s-1 value were evaluated after this (Figure 4). 
 
Figure 4 Ratio of loss (G") and storage (G') moduli of papaverine-HCl loaded 
precursor solutions as a function of HPC:PVA mass ratio (dynamic moduli measured at 
a frequency 1.995 Hz) 
 
On the dynamic moduli ratio vs. HPC:PVA mass ration diagram can be seen 
unambiguously that it has a local minimum at a sample of HPC:PVA=8:2 mass ratio. 
With the increasing HPC ratio, the G”/G’ value decrease monotonically, reaching a 
minimum, and after that, an increase can be observed. 
 
3.1.3. Morphology study of the electrospun samples 
The prepared papaverine-HCl-loaded HPC:PVA viscous solutions of constant 15 
%(w/w) polymer concentration, but with different polymer ratios were used for the 
electrospinning process. Each of the five precursor solutions of different polymer 
compositions was suitable for electrospinning, but with varying degrees of success. The 
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electrospinning of the precursors resulted in well-defined, round samples on the collector, 
from where the samples could be easily peeled off. This is particularly advantageous for 
further processability and also from the point of the final applicability. The composition 




Figure 5 SEM images of the papverine-HCl-loaded electrospun samples as a 
function of HPC:PVA mass ratio 5:5 (A), 6:4 (B), 7:3 (C), 8:2 (D), 9:1 (E) 
 
The morphology of the electrospun samples are shown in Figure 5. With the 
increasing HPC ratio to PVA morphology changes were obtained; spray-dried film-like 
structures, fibrous films, and clearly fibrous samples can be observed in the SEM images. 
At 9:1 HPC:PVA mass ratio, partial spray-dried film formation, and beaded fiber can be 
observed (Figure 5E). Electrospinning and electrostatic spraying co-occurred, which 
resulted in beaded fibers combined with film elements. In the case of 8:2 and 7:3 ratios, 
fibrous film morphology characteristics were obtained (Figure 5D and C, respectively), 
but in the latter case, the fibrous structure characterizes the whole fibrous film sample. 
SEM images of the electrospun samples of the two lowest (5:5 and 6:4) HPC ratio showed 
that random orientated, clearly fibrous structure without beads and film-like elements 
were achieved (Figure 5A and B, respectively). 
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As the HPC ratio was decreased, the fibrous characteristic became the dominant 
feature.  The transition of a predominantly fibrous system from film formation was 
initiated at 8:2 HPC:PVA ratio, and was completed by 6:4 ratio. With the decreasing HPC 
ratio of the precursor solution, the fibrous part of the electrospun samples noticeably 
increased. 
 
3.2. Solid-state characterization of the papaverine-HCl containing samples 
3.2.1. Results of the FTIR analysis 
FTIR measurements were carried out with the aim of characterizing the physical state 
of the API of the electrospun samples. The FTIR spectra of the electrospun samples, the 
physical mixture, and the solid components of the precursor solution are shown in Figure 
6.  In the spectra of the papaverine-HCl, the broad band system of the protonated amines 
can be observed between 2200-2800 cm-1, with a maximum at 2495 cm-1. The medium 
intensity bands are appearing above 3220 cm-1 are aromatic C-H vibrations, while the 
peaks at 2967-2840 cm-1 belonging to aliphatic C-H vibrations. The characteristic peak 
of the model drug between 2200-2800 cm-1 can be observed clearly in the physical 
mixture. These characteristic peaks were found to be selective, thus able to verify the 
physical state of the drug. Regardless of the polymer ratios, peaks belonging to the 




Figure 6 FTIR spectra of the components, physical mixture of the components and 
the drug-loaded electrospun sample of different hydroxypropyl cellulose (HPC) : 




3.2.2. Microstructural distinction by PALS measurements 
In order to monitor the supramolecular alternations of the electrospun samples and the 
corresponding physical mixtures, PALS measurements were carried out.  
 
Figure 7 Ortho-positronium (o-Ps) lifetime values of papaverine-HCl loaded 
electrospun fibrous samples of different HPC:PVA mass ratio and the corresponding 
physical mixtures 
 
Figure 7 shows the average discrete o-Ps lifetime values of the nanofibers electrospun 
from precursors of different HPC:PVA ratios and the corresponding physical mixtures. 
(The electrospun sample of HPC:PVA 9:1 ratio was not suitable for this investigation.) 
For each composition, decreased o-Ps values for electrospun samples can be observed in 
contrast to the corresponding physical mixtures. 
 
3.3. Accelerated stability test of the papaverine-HCl containing electrospun 
sample of HPC:PVA 6:4 mass ratio 
3.3.1. Morphology study of the stored electrospun samples 
The stress induced morphological changes of the fibrous sample of HPC:PVA 6:4 
mass ratio were tracked by SEM measurements. The time-dependent morphological 




Figure 8 SEM morphology of the freshly prepared (unstored) and the stored 
papaverine-HCl loaded electrospun sample of HPC:PVA 6:4 (m:m) 
 
Despite that the fibrous structure was basically preserved until the end of the stability 
test; remarkable structural changes took place. The fibrous structure was deteriorated by 
the stress conditions in two major steps. Firstly, the merging and broadening of the 
individual fibers can be observed, and thus the fiber-film like transition was started, which 
became more pronounced as storage time progressed. Secondly, fragmentation occurred, 
which was manifested in the formation of tenuous initiative scraps.  
 
3.3.2. Micro-and macrostructural investigation of the stored under stress condition 
FTIR measurements were carried out with the goal of the monitoring the physical state 
of the embedded drug. FTIR spectra of papaverine-HCl loaded electrospun samples as a 




Figure 9 FTIR spectra of papaverine-HCl, the physical mixture, the freshly prepared 
and the stores (week1-4) electrospun sample of HPC:PVA=6:4 (m:m) 
 
On the spectra of the freshly prepared sample, high-intensity selective characteristic 
peaks related to the API around 2500 cm-1, which belonging to the protonated amine 
group of the API, could not be observed. Some peaks were merging and broadening, as 
was expected based on the preliminary study (which was discussed in detail in 3.2.1 
chapter).  
Unexpectedly, already after one week of storage, the peaks around at 2500 cm-1 
appeared, which was possibly related to the API and persisted until the end of the stability 
test. In the case of all the sampling points, the relative intensity of this peak remained 




Raman spectroscopy analysis were performed to monitoring the stress tolerance 
capacity of the formulation.  The vibrational characterization of the samples can be seen 
in Figure 10 and Figure 11. 
 
Figure 10 Raman spectra of the samples between 400 and 3500 cm-1 
 
Visible characteristic peaks of the API appeared in the spectrum of the physical 
mixture, which is referred to the crystalline state of the drug. In contrast to the freshly 
electrospun sample, where the merged spectral pattern could be observed, spectra of the 
stored samples showed a progressive change until it reached a profile like the physical 




Figure 11 Raman spectra of the samples between 400 and 800 cm-1 
 
The shifting of the peak was notable only in one case; the CH-stretching vibrations of 
the API around at 2938 cm-1 wavenumber. Along with the storage time, the peak shifts 
were the following: -4.9 cm-1, -1.9 cm-1, -2.9 cm-1, -2.9 cm-1 and -2.9 cm-1 for week 0, 1, 




Figure 12 The shape of the Raman spectra of the region between 50 and 200 cm-1 
 
After a more thorough examination of the region of 50–200 cm-1 assigned as lattice 
vibration, a time-dependent process can be inferred related to the solid-state changes of 
the drug-containing polymeric system (Figure 12).  
 
Figure 13 Integrated area of the Raman peak (at 85 cm-1) of the physical mixture, 
freshly prepared and stored (weeks 1-4) papaverine-HCl loaded electrospun samples of 
HPC:PVA=6:4 mass ratio between  
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The spectral profile and the integrated area of the region between 50 and 200 cm-1 were 
becoming more and more similar to the characteristic feature of the physical mixture, 
which indicated that the amorphous to crystalline transition of the drug took place as a 
result of the exposition to stress conditions (Figure 13). 
It was also observed that the characteristic peaks in the region of 700–780 cm-1 related 
to the benzene and isoquinoline ring out of plane deformation and the C-C-C bond (which 
connects the two rings) deformation merged into the baseline, and then along with the 
storage time, these peaks were re-separated (95). 
After a detailed analysis of the spectra in the region of 430–700 cm-1, where peaks of 
the wagging vibrations of methoxy moieties (463 cm-1 and 473 cm-1), out of plane 
deformations of the rings (533 cm-1, 563 cm-1), in-plane and out of plane deformations of 
the rings and twisting vibrations of methoxy moieties (647 and 662 cm-1, respectively) 
can be noticed (Figure 11) (95). 
The aging related microstructural changes of the drug-loaded fibrous sample of 
HPC:PVA 6:4 mass ratio was detected by PALS measurements.  The average discrete o-
Ps lifetimes as a function of storage time showed a two-step process of a supramolecular 
alternation. One week storage in stress conditions resulted in the increase of third-lifetime 
value and thus larger free volume holes. After that, a sharp drop can be observed, and 
then a consecutive remarkable increase in o-Ps lifetime values can be noticed. 
 
Figure 14 Average discrete ortho-positronium (o-Ps) lifetimes of the papaverine-HCl 




The two-step aging process was obviously detectable in the distribution curves of o-
Ps lifetimes (Figure 14), implying multiple supramolecular changes throughout the 
stability test.  
 
 
Figure 15 The ortho-positronium (o-Ps) lifetime distributions in the papaverine-HCl-
loaded electrospun nanofibers of HPC:PVA=6:4 mass ratio, after 0, 1, 2, 3, 4 weeks of 
storage (t0, t1, t2, t3, t4) 
A definite change could be observed in the distribution in terms of the width as well 
in the average values after one week of storage. This process was followed by a second 
rearrangement, where backward shift and narrowing of the distributions could be noticed 
unambiguously. With the progressed storage time, the peak at 1.951 ns, indicative of o-
Ps atoms shifted towards longer lifetimes (o-Ps=2.038 ns after one week), which referred 
to the increase of free volume holes in size and could arise as a consequence of the 
relaxation of the structure (Figure 15). 
 
3.4. Morphology, topography and mechanical properties of the MH-loaded 
fibrous samples 
MH-loaded, aqueous viscous PVA solutions of two different compositions were 
prepared, and fibrous samples were manufactured with electrospinning. After the 
optimization of the fiber formation process parameters and compositions of the viscous 
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solutions for the electrospinning process, well-defined, round-shaped samples were 
achieved on the collector. Randomly oriented, clear fibrous structure without any beads 
and film-like areas can be observed in the SEM images of each sample (Figure 16).  
 
Figure 16 SEM photos of the poly(vinyl alcohol)-based, metoclopramide-HCl-
loaded electrospun sample either containing polysorbate 80 (PVA-PS-MH) (A, B) or 
hydroxypropyl-β-cyclodextrin (PVA-CD-MH) (C, D)   
(Magnification: 3500× (A, C) and 10000× (B, D) 
On the SEM images, clusters or any visible signs of heterogeneity could not be 
detected in either sample e.g., surface crystallization of the active pharmaceutical 
ingredient and other artifacts was missing. In the case of the PVA-PS-MH sample, a more 





Figure 17 Histograms of the fiber diameter distribution of metoclopramide-HCl-
loaded electrospun sample either containing polysorbate 80 (PVA-PS-MH) (A) or 
hydroxypropyl-β-cyclodextrin (PVA-CD-MH) (B)  
 
336±88 nm and 323±62 nm (mean ±SD) average fiber diameter values were achieved 
for PVA-PS-MH and PVA-CD-MH electrospun samples, respectively. In the case of the 
PVA-PS-MH sample, a slightly wider fiber distribution was obtained than that of the 
PVA-CD-MH fibers with a more uniform structure (Figure 17).  
Fiber diameter distributions of the two electrospun samples were investigated using 
the Kolmogorov–Smirnov test, which indicated that distributions of PVA-PS-MH and 
PVA-CD-MH fibers were normal (p = 0.844 and 0.416, respectively). A one-way analysis 
of variance (ANOVA) revealed that no significant difference between the diameter of the 





Figure 18 AFM amplitude-contrast images of poly(vinyl alcohol)-based, 
metoclopramide-HCl-loaded, either containing polysorbate 80 (PVA-PS-MH) (A, B, C) 
or hydroxypropyl-β-cyclodextrin (PVA-CD-MH)(D, E, F) nanofibers.  
Panel B and E are higher resolution images of areas indicated by yellow rectangles 
on panel A and D, respectively. Height sections (C, F) taken alongside the green dashed 
line in panel B and E, respectively. 
 
AFM topography of both PVA-PS-MH (Figure 18A and B) and PVA-CD-MH 
(Figure 18D and E) fibrous sample appeared similar to those seen in SEM images 
(Figure 16). The PVA-CD-MH fibers appeared as long, curved, continuous, cylinders. 
In the case of PVA-PS-MH fibers, some ribbon-like, flat structure can also be observed 
(see top left and bottom right corners in Figure 18A).  
The height of the investigated regions of the fibers varied between 330-360 nm and 
300-450 nm for PVA-PS-MH and PVA-CD-MH fibers, respectively. Relatively smooth 
fiber surface with only a few nm height variations was observed in the case of both MH-
loaded nanofibrous formulations. The height profile of PVA-PS-MH fibers (Figure 18C) 
showed sharper peaks than the cyclodextrin containing ones, which had a more rounded 
profile plot (Figure 18F), indicating that PVA-PS-MH fibers display a bit coarser surface. 
For the investigation of the mechanical properties of the PVA-based nanofibers 
formulated with different excipients by AFM, 100 nN, 500 nN, 1 µN and 5 µN loads were 
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applied at well-defined points of the fiber surface, that was pressed and retracted with the 
AFM tip at a constant 1 µm/s velocity.  
 
 
Figure 19 Effect of the mechanomanipulation: AFM-amplitude contrast images of 
metoclopramide-HCl-loaded electrospun fibers either containing polysorbate 80 (PVA-
PS-MH) (A) or hydroxypropyl-β-cyclodextrin (PVA-CD-MH) (B) taken after force 
spectroscopy. The yellow rectangles indicate areas where force maps (10 × 10 force 
curves) were taken from. The maximum load applied in each region is written next to 
the rectangles. 
 
The manipulated area was re-scanned. No noticeable alternations were found in 
regions loaded with 100 nN forces (Figure 19). At 500 nN load, few small depressions 
were seen for PVA-CD-MH fibers, while in the case of the PVA-PS-MH sample, no 
effect was detected. 
Nevertheless, in both formulations at 1 µN and 5 µN loads, permanent surface 
depressions were observed; thus, these forces enabled plastic deformation. Shallower and 
blurred depressions were obtained in PVA-PS-MH fibers (Figure 19A), while in PVA-
CD-MH fibers, those were deeper and had a more definite profile reflecting the shape of 
AFM tips (Figure 19B). 





Figure 20 Representative force curves taken from metoclopramide-HCl-loaded 
either polysorbate 80 containing (left panels) or hydroxypropyl-β-cyclodextrin 
containing (right panels) nanofibers at 100 nN (A, B), 500 nN (C, D), 1 µN (E, F), 5 




The negative peak in approach curves in case of 100 nN maximum load can refer to a 
considerable attractive interaction between the fibers and the tip. 
At 0 nm distance, where the fiber surface was reached, the force followed an apparent 
linear increase up to the threshold load (~100 nN), which is a sign of the elastic response. 
When the tip was retracted, the force was decreased, and the retraction curve was roughly 
parallel to the approach curve. Only a minimal hysteresis can be observed between the 
two curves, suggesting that at this load there was no plastic deformation. 
The large negative force peak of the retraction curve is the consequence of the tip-fiber 
adhesion, and then the force reached 0 as the tip was drawn farther from the fiber surface. 
The ascending force region of approach curves was fitted with the Hertz-model of 
elasticity (96) that adapted to AFM force spectroscopy (Figure 20A and B dotted lines). 
According to distributions of Young's modulus calculated from the fits, in both cases 
apparent normal distribution was achieved, and for PVA-PS-MH and PVA-CD-MH 




Figure 21 Histogram of Young-moduli and plasticity of the metoclopramide-HCl-
loaded fibers formed either polysorbate 80 containing (PVA-PS-MH) or hydroxypropyl-
β-cyclodextrin (PVA-CD-MH) 
 
With the increasing loads, the hysteresis area between the approach and the retraction 
curves was larger, which was referred to as a plastic deformation of the fibers. In the case 
of the PVA-CD-MH sample, a larger hysteresis area can be observed at each applied load; 
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thus, this fibrous formulation is more plastic (plasticity distributions at 5 µN load can see 
in Figure 21B, as it was concluded from Figure 19. 
 
3.5. Solid-state characterization of the MH-loaded electrospun samples  
PALS measurements were performed to monitor supramolecular changes through 
changing of the o-Ps lifetime values of the physical mixtures, electrospun neat- and drug-
loaded fibrous samples. The o-Ps lifetimes of the physical mixtures were found to be 
roughly the same regardless of the used excipients. The o-Ps lifetime values of PS 
containing nanofibrous samples (PVA-PS and PVA-PS-MH samples) were increased 
relative to the physical mixture (Figure 22). 
 
 
Figure 22 Average discrete ortho-positronium (o-Ps) lifetimes of either polysorbate 
or cyclodextrin containing neat samples, drug-loaded nanofibers, and related physical 
mixtures 
 
The presence of the embedded drug does not modify the average free volume holes 
appreciably and thus the supramolecular structure; while the o-Ps lifetime of PVA-CD 
and PVA-CD-MH, neat and drug-loaded electrospun samples remarkably decreased 
compared to the physical mixture. The drug incorporation into the fibers caused a further 




Figure 23 FTIR spectra of the solid components (metoclopramide-HCl (MH), 
poly(vinyl alcohol) (PVA), hydroxypropyl-β-cyclodextrin (HP-β-CD)) and the drug-
loaded polysorbate (PVA-PS-MH) and hydroxypropyl-β-cyclodextrin (HP-β-CD) 
containing nanofibrous samples and the corresponding physical mixtures 
 
Figure 23 shows the FTIR spectra of the starting materials used for precursor 
preparation, electrospun samples, and the corresponding physical mixtures. Characteristic 
peaks relating to the OH- (at 3320-3340 cm-1), NH-(at ~3190 cm-1), CH- (at 2910-2940 
cm-1) bending and NH-stretching (at around 2635 cm-1) vibrations of the MH can be 
observed clearly in the physical mixture. As the other characteristic peaks of MH 
overlapped with peaks attributed to functional groups of the excipients, the changes of 
NH signs were evaluated to verify the solid-state transition of the model drug (MH). In 
the spectra of the fibrous samples, the high-intensity characteristic peaks of the NH-





Figure 24  Power X-ray patterns of the solid components (metoclopramide-HCl 
(MH), poly(vinyl alcohol) (PVA), hydroxypropyl-β-cyclodextrin (HP-β-CD)) and the 
drug-loaded polysorbate (PVA-PS-MH) and hydroxypropyl-β-cyclodextrin (HP-β-CD) 
containing nanofibrous samples and the corresponding physical mixtures 
 
Characteristic peaks of the MH and the broad peak of the PVA and CD appeared in 
the X-ray diffractograms of the physical mixture (Figure 24). While the XRD patterns of 
the drug-loaded fibrous samples could be characterized by diffuse peaks, high-intensity 
characteristic peaks relating to the MH did not appear. 
The local anesthetic agent lidocaine is a substituted benzamide derivate as the model 
drug, but its inclusion complexation with HP-β-CD has already been described and 
widely studied in the literature (97). Due to the structural similarity of the two drugs, 
interactions between MH and the randomly substituted HP-β-CD at an atomic level was 
investigated by two dimensional rotating-frame nuclear overhauser effect spectroscopy 




Figure 25 Partial 2D ROESY NMR spectrum of metoclopramide-HCl and randomly 
substituted hydroxypropyl-β-cyclodextrin (HP-β-CD) 
 
Figure 25 represents a partial ROESY spectrum of the MH-HP-β-CD system, where 
between the aromatic 1H resonances of MH and the inner cavity protons of HP-β-CD 
(CD-H3 and CD-H5) intense cross-peaks were clearly depicted. Cross-peaks can be 
observed between the resonances of the aromatic moiety of MH and the hydroxypropyl 
chains of the CD. 
ssNMR measurements were performed with that goal to characterize the PVA-based 
nanofibrous systems. In the case of the measurement of MH, a well-resolved NMR 
spectrum typical for crystalline materials built up of small molecules was achieved. 
Based on the single pulse experiment with 600 s of recycling delay, all of the resonance 
could be assigned to one carbon atom. In the crystalline structure, the N-ethyl groups have 
a different environment; therefore, their signals differ remarkably from those obtained in 




Figure 26 Solid-state NMR spectra of metoclopramide-HCl (MH) and the nanofibers 
 
Signals of the methyl groups at 9.9, and 3.7 ppm were found to be especially sensitive 
for the detection of the even low ratio of crystalline ordering in the complex matrix 
systems. The spectra of the electrospun fibrous samples only showed broadened signals 
in a wide range (Figure 26). The resonance of MH overlapped with the signals of 
polymeric matrices. The exceptions were only the methyl and some aromatic signals of 
the model drug. The sharp MH signals of the crystalline materials (that were used for the 
precursor preparation for the electrospinning process) were merged and broadened in the 
spectra of the fibrous samples that unequivocally indicate that the MH has no crystalline 
structure in the fibers. 
On the spectra, a slightly shifted signal can be observed instead of the two methyl 
resonances; thus, the short-range order could be ruled out on an nm scale. 
Information can be obtained with the evaluation of the proton environment of the 
carbon atoms and their mobility by the analysis of the shapes of the CP build-up curves, 
which are constructed by varying the contact time and plotting signal intensity vs. contact 
time. 
Fitting of the build-up curves by a simplified expression determination of changes in 
the chemical environment and relaxation of carbons (according to the Equation 2) was 
possible: 
 
𝑀(𝑡) = 𝜆−1𝑀0[1 − exp (−𝜆𝑡 𝑇𝐶𝐻)⁄ ]exp⁡(− 𝑡 𝑇1)⁄     (2) 
 
where  = 1+(TCH/T1)-(TCH/ T1), M(t) is the magnetization at contact time t, M0 is the 
initial magnetization, TCH is the time coefficient of the CP (the time it takes for 
DOI:10.14753/SE.2020.2446
35 
magnetization to be transferred from 1H to 13C), and T1 is the relaxation time of the 
carbon in the rotating frame. This equation is valid only in a regime of fast molecular 
motion, but it qualitatively describes the experimental CP build-up curves and permits a 
comparison of the fitted parameters.  
 
 
Figure 27 13C cross-polarization Magic Angle Spinning build-up curve of the 
metoclopramide-HCl loaded polysorbate (PVA-PS-MH) (A) and hydroxypropyl-β-
cyclodextrin (PVA-CD-MH) (B) containing nanofibers 
This equation is valid only for fast molecular motion, but qualitatively describes the 
experimental CP build-up curves and allows comparison of the fitted parameters (Figure 
27). 
The more mobile a carbon, the more slowly it relaxes, so the plasticizing effect of the 
excipients could be efficiently tracked. Because of the numerous overlaps of the signals, 
only the signal of PVA at 43.3 ppm was analyzed in detail. The resonance (at 75.3 ppm) 
attributed to the crystalline PVA decreases or even disappears in the plasticized samples 
(98). 
 
Figure 28 Solid-state NMR spectra of poly(vinyl alcohol) (PVA) and 




This effect is clearly observable on the 13C NMR spectra of the PVA-PS-MH sample 
(Figure 28), but it is not recognizable on the PVA-CD sample, because of the overlapping 
signals. 
The H-bond structure remained unaltered; consequently, the hydrogen environment 
did not change significantly around the CH2 groups; thus, the TCH parameter did not 
change remarkably. The H-bonds formed between the adjacent chains exchanged to H-
bonds between PVA and plasticizer molecules in the plasticized electrospun PVA-based 
fibrous samples. The mobility changes are more explicit, so the plasticization effect 
reflected in the T1rho relaxation parameter is evident (Figure 29). The mobility of PVA 
chains was found to be similar in both fibrous samples. In the case of the MH-loaded 
fibrous samples, the chain mobility increased further, indicating that the API also acts as 
a plasticizer. 
 
Figure 29 Solid-state NMR relaxation times of neat- and MH-loaded polysorbate 
(PS) or cyclodextrin(CD) containing nanofibrous sample 
 
The amorphous nature of the electrospun PVA-based ASDs was characterized by the 
sensitive ssNMR method through the tendency of T1rho values. A slight difference was 
achieved between the T1rho values of the CD containing neat (PVA-CD) and drug-loaded 
(PVA-CD-MH) samples, while the relaxation time difference was remarkably higher 
between the PVA-PS and the PVA-PS-MH samples.  
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3.6. Stability investigation of the MH-loaded electrospun samples 
The ASDs, e.g., the polymeric-based amorphous drug-loaded electrospun nanofibrous 
systems, have a thermodynamically metastable nature, thus achieving long term stability 
of these systems, their physicochemical stabilization has a great impact and special 
interest.  
Accelerated stability tests of the electrospun samples are described in this chapter. In 
the case of each formulation, the stress indicated solid-state stability, and supramolecular 
changes of the stored samples were investigated with image techniques (SEM), 





Figure 30 SEM photos of the stored (1-4 weeks) of the metoclopramide-HCl loaded 
polysorbate (PVA-PS-MH samples) (A) or hydroxypropyl-β-cyclodextrin (PVA-CD-
MH samples) (B) containing nanofibers  
 
The stress-induced time-dependent morphological changes of the MH-loaded fibrous 
samples were tracked by SEM measurements, and no remarkable changes in the 
morphological features of the electrospun samples have been detected (Figure 30A for 
PVA-PS-MH and Figure 30B for PVA-CD-MH sample). For either formulation, no 
fiber-to film transition or fragmentation could be observed. The integrity of the fibrous 
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structure was maintained for the four weeks of storage. On the images of the oldest 
PVA-PS-MH sample, slightly merged and broadened fiber segments could be seen.  
The macrostructural alterations were monitored by XRD measurements.  
 
Figure 31 Power X-ray patterns of the stored (1-4 weeks) of the metoclopramide-
HCl loaded polysorbate (PVA-PS-MH) or hydroxypropyl-β-cyclodextrin (PVA-CD-
MH) containing nanofibers and the corresponding freshly prepared physical mixtures 
 
In the course of the storage, no characteristic peaks of the API appeared on the 
diffractograms of the stored fibrous samples (Figure 31A for PVA-PS-MH and Figure 





Figure 32 Discrete ortho-positronium (o-Ps) lifetimes  of the stored (1-4 weeks) 
neat- and metoclopramide-HCl loaded polysorbate (PVA-PS and PVA-PS-MH, 
respectively) or hydroxypropyl-β-cyclodextrin (PVA-CD and PVA-CD-MH, 
respectively) containing nanofibers 
The PALS method was chosen for tracking the aging-related changes of the polymer-
based drug carriers. As the storage proceeded, the observed difference between the o-Ps 
values of the neat and drug-loaded PS containing stored fibrous samples became slightly 
larger: 0.046 ns, 0.059 ns, 0.062 ns, and 0.072 ns for week 1, 2, 3 and 4, respectively 
(Figure 32A). In the case of the HP-β-CD containing PVA-CD and PVA-CD-MH 
samples, the o-Ps lifetimes and consequently the average free volume holes were found 
to be nearly the same during the storage period (Figure 32B). 
 
3.7. Results of the in vitro study of the MH-loaded electrospun nanofibrous sheets   
For the PVA-PS-MH and PVA-CD-MH electrospun samples, 16.45±0.25 % (w/w) 
and 14.24±0.27 % (w/w) drug content was achieved, respectively. 
The MH distributions in the nanofibrous orally dissolving webs and the corresponding 
physical mixtures, which could be the base of a tablet formulation, were investigated by 
Raman mapping. As the amorphous form of the API as a pure component was not 
available for the analysis and the evaluation, thus, to extract the missing amorphous 





Figure 33 Raman spectra of the crystalline and amorphous metoclopramide-HCl 
 
The Raman spectra of the crystalline form and the amorphous form of the API (as a 
result of the chemometric analysis) are shown in Figure 33, where the detectable 
difference between the forms could be tracked. On the spectra of the amorphous reference 
form, the broadened and merged signals could be seen.  
 
Figure 34 Raman maps of polysorbate (A) and cyclodextrin (B) containing 
metoclopramide-HCl-loaded fibers and the corresponding physical mixtures (C, D) 
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The Raman map of the PVA-PS-MH electrospun sample and the corresponding 
physical mixture can see in Figure 34A and C respectively, while Figure 34B and D 
represent the maps of the HP-β-CD containing the nanofibrous sample and the 
corresponding physical mixture. In the case of both nanofibrous samples, the relative MH 
concentration values were about the same in each sampling point; only a slight difference 
could be observed, while in the case of the physical mixtures, remarkable MH 
concentration fluctuation was achieved. 
 
 
Figure 35 In vitro dissolution test of the metoclopramide-HCl loaded polysorbate 
(PVA-PS-MH) or hydroxypropyl-β-cyclodextrin (PVA-CD-MH) containing 
nanofibrous samples carried out at phosphate  
 
Figure 35 shows the dissolution profile of the MH containing electrospun nanofibrous 
samples formulated with different excipients. As it is expected based on, e.g., our 
previously published study (68), rapid and complete in vitro drug release was achieved 
when the fibrous formulation contained PS. Slightly slower, but also complete dissolution 




4.1. Preformulation and characterization of papaverine-HCl-loaded samples 
4.1.1. Preformulation study of papaverine-HCl-loaded samples 
Some degree of overlap is required for successful electrospun fiber production. 
Optimal entanglement, where the contact between the polymeric chains resulting in a 
flexible supramolecular structure to the polymer precursor solution, is developed at a 
given concentration range and manifested in excellent fiber formation properties. If 
excessive chain entanglement takes place, which hinders the free movement of the 
polymer chains, the film formation becomes more pronounced instead of the randomly 
oriented individual fiber formation. The results can be explained by the change of the 
entanglements of polymeric chains. The reason is to be found in the dependence of the 
molar reflectance and rheological parameters of the inter- and intrachain interaction of 
polymers. 
The molar reflectance measurements suggest that with the increasing HPC content, the 
entanglements of the polymer chains became more pronounced, which was 
disadvantageous from the point of the fiber formation process. From the nearly same 
space-filling factor values, similar molecular mobility can be inferred. The observed 
opposite trend in R values (Rm and Rc) and the HPC ratio implies that no specific 
intermolecular interaction between the polymers was established. Nonetheless, the 
observed divergence refers to a slight but non-specific intermolecular interaction, e.g., 
hydrogen bonding or altered chain entanglement, which was the most effective in the case 
of HPC:PVA 8:2, 9:1 and 7:3 mass ratios. 
The smallest moduli ratio entails the most elastic behavior of the composite precursor 
solution relative to the other solutions of different polymer ratios. This indicated that the 
overwhelming viscoelasticity of the precursors could be disadvantageous from the point 
of fiber formation, because the applied electrical forces could not be transferred with 
adequate efficiency to the viscoelastic elongation of the polymer jets in the course of the 
electrospinning process. Polymeric precursors of the smallest G”/G’ ratio, so with the 
most elastic behavior, resulted in film formation, while in the case of the less elastic 
behavior of the viscous solutions for the electrospinning more fibrous structures were 
obtained. It can be concluded that for successful fiber formation, the precursor solution 
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should have viscoelastic nature, on the other hand too high elasticity is unfavorable in this 
respect.  
 
4.1.2. Micro-and macrostructural investigation of the papaverine-HCl containing 
samples 
The FT-IR results suggest that the papaverine embedded into the fibers in an 
amorphous state regardless of the two polymer ratios.  
According to the PALS results, denser supramolecular structures were formed as a 
result of the electrospinning process, which was indicated by the decreased o-Ps lifetime 
values of the electrospun sample of different polymer compositions and manifested in 
smaller free volume holes. 
 
4.1.3. Accelerated stability test 
The merged and broadened FTIR and Raman bands of the fresh sample indicated that 
the API embedded into the polymeric carrier in an amorphous state. The appearing 
characteristic peaks in the spectra of the stored samples suggested that the 
recrystallization of the API took place. The latter fact is in good agreement with the 
observed phenomenon of the morphological evaluation. It can track back to limited 
conformational and molecular mobility of the moieties of the crystalline materials, which 
were manifested in sharp characteristic peaks. In contrast, in an amorphous state, there 
are numerous allowed conformations, and the energy can be distributed between them 
and can lead to a merged and broadened spectral profile. 
The effects of higher temperature and elevated humidity remarkably affect the 
molecular mobility and the secondary intermolecular interactions, namely, increasing the 
former and decreasing the latter. These changes can presumably predispose the ASD for 
the physical-state modification, and the escalation of the molecular mobility can make a 
significant contribution to the chances that amorphous APIs start to form crystals.  
The preliminary study showed that only weak secondary inter- and intramolecular 
interactions occurred between the compound of the polymeric system, which also 
confirms that even a slight temperature rise can be sufficient to destroy or decrease these 
attractive forces. The established weak secondary interactions were beneficial for fiber 
formation because, in this case, optimum molecular entanglement was achieved. On the 
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other hand, these interactions were not strong enough to prevent the increase of the 
molecular mobility, thus could not able to keep the API in an amorphous state during the 
stress-induced stability test. It follows that this was a drawback for the solid-state stability. 
The observed reduction in the intensity of the lattice vibrations could also be a 
consequence of the enhanced molecular mobility, which could lead to the recrystallization 
of the API via enthalpy relaxation.  
These observations of the supramolecular characterization may be due to the combined 
effect of a number of factors, e.g., the phase transition and redistribution of the API, the 
supramolecular restructuration of polymeric chains and the fragmentation of the fibrous 
structure. After the first week of storage, as a consequence of the elevated temperature, 
the molecular mobility of the polymer chains could increase, and thus the original 
polymeric structure was destroyed, and a new one was created (t1). The prolonged 
elevated temperature exposure of the fibers resulted in a different structure in the samples, 
which were stored for 2-4 weeks. The increase in temperature-driven mobility has 
sufficient force to overpower the intermolecular binding forces. The widening of the size 
distribution curves of the free volume holes without remarkable shifting towards larger 
holes (t1-t3) can be inferred that an intermediate structure was achieved. The fourth 
storage week induced widening of the o-Ps distribution curve, suggesting that a large 
fraction of “crosslinks” was destroyed by the enhanced molecular mobility, and the 
recrystallization of the API caused inhomogeneity in free volume hole size distributions.  
 
4.2. Formulation and characterization of MH-loaded electrospun samples 
4.2.1. Morphology and topography of the fibrous samples 
SEM and AFM images obviously showed that regardless of the used excipient, a 
clearly fibrous structure with uniform fiber surface was formed. It can be deemed, the 
PVA is a convenient polymer to be as the base of the matrix and incorporate the MH.  
The AFM measurements showed that loaded with relatively low forces (up to 100nN), 
largely elastic deformation was obtained. The achieved Young-moduli results: 3.26±1.74 
GPa and 1.48±0.90 GPa mean±SD values for PVA-PS-MH and PVA-CD-MH fibers, 
respectively are in good accordance with trifluoroacetate-derived PVA films value of 1.5-
3.75 GPa (99), that can be found in the literature. At this point, it should be mentioned 
that Young moduli of different PVA polymers that are reported previously vary in a very 
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broad range (e.g., 6.4 MPa (100) 1.8-4.7 GPa (101), 32.6 GPa (102), 50 GPa (103)), which 
could be a consequence of the different compositions, preparation techniques and the 
applied testing methods. When the fibers were subjected to higher loads (up to 5 µN), the 
resulted deformation was predominantly plastic. From the plasticity values that were 
calculated from force spectra and from that phenomenon, 500 nN load led to deformation 
only in PVA-CD-MH fiber. Thus it can be concluded that the PVA-CD-MH fibers are 
more plastic than the PS containing ones. By and large, the addition of PS80 resulted in 
two times stiffer, less plastic nanofibers than the use of HP-β-CD.  
 
4.2.2. Solid-state characterization of the electrospun samples 
The CP build-up curves indicated that the HP-β-CD behavior was found to be very 
similar to PVA (Figure 27B), in contrast with the liquid-like behavior of PS80 (Figure 
27A) that indicates that HP-β-CD acts as an inner plasticizer, while PS80 acts an outer 
plasticizer (104).  
The third lifetime values of the PALS results also revealed the different plasticizing 
effect of the used excipients; the ssNMR disclosed mobility and diffusibility differences 
of the nanofibrous samples (105). The enhanced mobility and diffusibility of the PVA-
PS-MH sample caused by the PS80 manifested in the increased o-Ps lifetime value of the 
fibrous sample related to the physical mixture. The remarkable reduction in o-Ps lifetime 
values of the HP-β-CD containing electrospun samples, and consequently in the average 
size of the free volume holes, implied the supramolecular ordering of the polymeric 
chains, resulting in a more complex molecular packing. 
The XRD characteristic of the fibrous samples, together with their FTIR spectra, 
indicated the absence of a long term order, thus suggested that as a result of the 
electrospinning process, the MH embedded into the fibers in the amorphous state, 
regardless of the formulations.  
The ssNMR also verified the amorphous state of the API; furthermore, this method 
was suitable for clarifying the amorphous nature of the active agent. Nonetheless, this 
piece of information proved to be very useful during the formulation design, as the true 
solid solutions have thermodynamical stability alone; the nature of the amorphous 
systems is not widely studied and described in the literature (57, 58). The slight difference 
between the T1rho relaxation parameters of the neat- and MH-loaded CD containing 
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formulations implied that the amorphous API in the PVA-CD-MH electrospun sample 
were molecularly dispersed. In contrast to the observed higher T1rho relaxations difference 
in the case of the PS containing formulation, indicated that the amorphous drug 
distributed inhomogeneously in the matrix, which leads to the formation of clusters and 
amorphous solid dispersions. 
The 2D ROESY NMR spectra indicated that the aromatic part of the API is in close 
proximity to the cavity of the CD, which suggests the formation of the inclusion complex. 
The cross-peaks between the hydroxypropyl chains of the CD and the MH shows that 
external complex formation also took place. From the very complex complexation results 
obtained in concentrated liquid solution together with that fact that the solvent 
evaporation during the electrospinning was extremely fast, we can assume that the formed 
structure probably also remained in the solid-state. In the case of the other formulation, 
based on the chemical structure of the compounds, only weaker secondary interaction 
formation is possible. Nonetheless, in both formulations, regardless of the used excipient, 
the established interactions were able to moderate the molecular mobility and obstruct the 
enthalpy relaxation. Thus the recrystallization of the amorphous drug could not occur, 
which may provide a clear explanation for why the MH remained in an amorphous form 
until the end of the four-week-long accelerated stability test. 
 
4.2.3. Stability investigation of the MH-loaded electrospun samples 
The PALS results of the stored samples indicated that the supramolecular structure of 
the drug-loaded HP-β-CD containing nanofibrous samples did not change remarkably. 
This could be attributed to the host-guest complexation and thus the molecular packing 
enhancer property of the CD.  The observed o-Ps values of the stored PVA-PS-MH 
samples based on established weaker interaction formation ability of this sample, together 
with that fact that the PS, as a liquid-like plasticizer can migrate in the fiber and could 
destroy the already formed secondary-bonds was manifested in time-dependent structural 
changes, which started during the four-week storage period and is likely to become 
progressively even more pronounced. 
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4.2.4. In vitro study of the MH-loaded electrospun nanofibrous sheets   
The spectrophotometric measurements that focused on the determination of the drug 
content of the electrospun samples indicated that the total amount of the MH incorporated 
into the fibers. 
From the Raman maps, it can be deduced that the MH molecules were distributed 
homogenously in the electrospun nanofibrous sheets, which has obviously a crucial role 
in formulation development and which may derive from the fast solvent evaporation 
during the fiber formation process. The greater extent inhomogeneity of the physical 
mixtures than that of the fibrous samples, suggests that the latter is easier to dose, which 
could have great importance for low-dose and low therapeutic index drugs. 
The fast and complete drug-release characteristic of PVA-PS-MH nanofibrous sample 
can be backtracked to the enhanced apparent aqueous solubility of amorphous drug 
delivery systems. This may also be due to the unique fiber characteristic (high surface 
area to volume ratio of fibers) and also to the wettability enhancing effect of the used 
surfactant. The slightly slower MH-release of the PVA-CD-MH sample can be attributed 
to the established stronger intermolecular interactions between the CD-MH-PVA.  
The enhanced molecular mobility of the PVA may also contribute to achieving 







5.  CONCLUSIONS 
The hydrophilic polymer-based nanofibrous orally dissolving sheets prepared by 
electrospinning are promising candidates for rapid drug release. The intraoral (e.g., 
buccal) administration aims at the concerns associated with pre-systemic metabolism 
(e.g., first-pass metabolism) and the consequential oral bioavailability. The fibrous 
formulation solves the solubility related issues, which is due to the unique morphological 
properties of the fibers. Moreover, as a result of the fiber formation process, an amorphous 
drug delivery system can be formed. The short-term ordering of these systems is the most 
responsible for these physical- and /or chemical instability.  
In my work, the primary focus was put into the more in-depth examination of the 
stress-indicated changes. Furthermore, I aimed to understand the stabilization 
opportunities of the electrospun samples based on the relationship between the precursor 
solution and the features of the resulting third-generation solid dispersions which can help 
in rational precursor design. Papaverine-HCl was chosen as a model drug, and HPC-PVA 
composite based nanofibrous sheets were prepared by electrospinning technique from 
aqueous precursor solutions. Based on the scientific literature, it was the first time that 
the fiber-forming capability of the poor electrospinnability HPC was improved with PVA, 
and the fiber formation was carried out without organic solvent usage. The combination 
of the two polymers allowed adequate composite fiber preparation with slightly different 
morphological features. 
During the fiber formation, five different precursor solutions of HPC:PVA 9:1, 8:2, 
7:3, 6:4, 5:5 mass ratios were successfully carried out. The optimum composition of the 
viscous solutions for the electrospinning process was selected by the combination of the 
dynamic moduli measurements and molar reflectance characterization with SEM 
investigation. It was the first published study when the Lorentz-Lorenz analysis was used 
to predict the success of the fibrous sample formation by electrospinning. 
Along with changes in the polymer ratio, the rheological properties of the solutions, 
the established intra- and intermolecular interactions and the corresponding morphology 
of the electrospun sample were varied. With the decreasing HPC ratio, fiber formation 
became dominant. Polymeric precursors of the lowest elasticity and the smallest Lorentz-
Lorenz plot values resulted in the best fiber characteristics of the electrospun samples. 
Thereby, the combination of these measurements made it possible to determine the most 
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suitable precursor composition. The electrospinning of polymer composite precursor 
solutions resulted in the formation of amorphous drug delivery systems and the 
supramolecular ordering of the polymeric chain structure, regardless of the composition 
of the solution used for fiber formation. 
In the case of the investigated composite ratios, the formation of a clearly fibrous 
structure was observed only at HPC: PVA 5: 5 and 6: 4 ratios. As the HPC has a higher 
mucoadhesive property, the sample of 6:4 HPC: PVA ratio was chosen for the further 
study, and this system was subjected to an accelerated stability test. It was the first 
examination, to the best of our knowledge, in which the supramolecular changes during 
the physicochemical stability test of drug-loaded electrospun sheets through positron 
lifetime distribution was reported. Furthermore, the two-step aging process of the drug 
carrier was also demonstrated. Together with the additional Raman and FTIR 
measurements, the altered local chemical environment became detectable. Based on 
these, it can be concluded that the papaverine-HCl loaded nanofibers exhibited less 
appropriate stress tolerance capacity. The applied experimental setup was found to be 
suitable to track how the aging of the polymeric carrier reflected in the solid-state changes 
of the embedded drug.  
As for fiber formation, the established weak secondary interactions (formed 
between the API and polymers) were beneficial, because in this case, the optimum 
molecular entanglement could be achieved; however, this was detrimental to stability. 
It is also clear from the above that stability problems due to the metastable nature 
of amorphous materials are determinants that need to be emphasized during formulation 
development. To examine this issue in detail, the MH was chosen as a model drug, which 
was an excellent API due to its molecular structural features. It was successfully 
elucidated how the most commonly used solubilizing agent influenced the 
electrospinning process and the behavior of the nanofibrous sample. 
Both of the examined excipients (HP-β-CD and PS80) enabled the formation of 
fibrous structure from the MH containing PVA-based aqueous precursor.  The subtle 
changes attributed to the applied excipients were subjected to a state-of-the-art imaging 
and several solid-state characterization techniques. It was revealed that the use of 
polysorbate led to about two times stiffer, less plastic fibers than the addition of 
cyclodextrin. Consequently, PS80 advances elastic behavior, while the HP-β-CD 
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promotes the plastic features. MH-loaded nanofibers of different mechanical properties 
were prepared by electrospinning. 
The major novelty of the work was the identification of the plasticizing effect of 
the nanofibrous samples by ssNMR measurements. The 1H-13C NMR cross-polarization 
build-up curves showed that cyclodextrin acts as an inner, while polysorbate acts as an 
outer plasticizer, and the latter can migrate in the polymer matrix, which is due to its 
“liquid-like” feature. The PALS measurements confirmed the ssNMR results; it was able 
to show the molecular mobility differences of the two formulations.  
The solid-state methods with different sensitivity showed the short-term ordering 
of the embedded drug, so it suggests that amorphous drug delivery systems were formed 
regardless of the applied excipients, but with different homogeneities. The use of PS80 
was prone to cluster formation, which could be disadvantageous from the point of the 
long-term stability of this system, as recrystallization of the API is easier in this case. 
During the accelerated stability test, no change in the physical state of the MH, 
could be observed. Thus, it can be stated that the electrospun samples exhibited a large 
stress tolerance capacity. However, the use of PS80 resulted in time-dependent 
microstructural changes, which together with its enhanced cluster-formation ability can 
be the drawback of this formulation.  
Homogenous drug distribution, together with the rapid and complete drug 
dissolution, made the electrospun samples suitable for application as orally dissolving 
webs. The established stronger interaction in the case of the CD-containing formulation 
reflected in the rapid, but a little bit slower drug release compared to the PS-containing 
one. The two-step dissolution profile of the PVA-CD-MH electrospun sample could be a 
consequence of the different dissolution rates of the complexed drug and the free 
amorphous drug part. 
It can be established on the basis of the results presented in my dissertation that the 
complex physicochemical characterization of the polymer-based nanofibrous drug 
delivery systems it is of great importance. It contributes to a better understanding of 
material properties, including the supramolecular interactions of multicomponent 
systems, and consequently the rational design of drug-loaded nanofibrous carriers with 




Papaverine-hydrochloride loaded electrospun fibers were prepared for further intraoral 
administration with the aim of improving the oral bioavailability of the drug. Bases of the 
formulation, HPC was chosen, but the addition of the PVA to the precursor was 
successful, from the point of the electrospinnability. Preformulation studies were carried 
out by monitoring the rheological properties and the molar reflectance of the precursor 
solution of five different polymer ratios at a constant total polymer concentration, as well 
as the fiber morphology. A relationship was found between the examined properties of 
the polymer solutions and their electrospinnability, and the consequent morphology of 
the samples. The best fiber performance was achieved when the lowest elasticity and the 
smallest intermolecular interactions were found. Nonetheless, the morphology of the 
sample changed with the polymer ratio, ASDs were formed with a supramolecular 
ordered structure in both cases. The electrospun sample of HPC:PVA 6:4 ratio was found 
to the best and was subjected to an accelerated stability test. The partial recrystallization 
of the drug indicates the moderate stress tolerance capacity of the ASD, while the PALS 
measurements revealed the two-step aging process of the drug carrier.   
Several characterization techniques were used to investigate the effect of two different 
excipients on fiber formation properties, the behavior of the MH-loaded electrospun 
samples, and their stress-induced physical aging. The AFM measurements pointed out 
that clearly fibrous samples of viscoelastic nature were formed with different mechanical 
properties. The use of PS80 advances the elastic behavior, while the addition of the HP-
β-CD enhances plastic features. The observed supramolecular changes suggest the 
molecular mobility differences of the two formulations. The ssNMR measurements 
revealed that the PS80 acts as an outer-, while the CD acts as an inner plasticizer. The 
liquid-like structure of the former ones caused the enhanced molecular mobility of this 
formulation and its less plastic behavior. The ssNMR results suggested that different 
amorphous drug delivery systems were formed. The molecularly dispersed PVA-CD-MH 
system was found to be beneficial for long-term stability. Nonetheless, during the 4-week- 
long storage under stress conditions, recrystallization of the API was not observed. 
However, the established stronger interactions in the case of PVA-CD-MH samples were 
reflected in the unchanged microstructure under stress condition and in the little bit 
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a  r  t  i c  l  e  i  n f o
Article history:
Received 31  December 2016
Received in revised form 14 February 2017
Accepted 15  February 2017






Storage and loss moduli
Molar reflectance
a  b  s t  r a  c t
Papaverine  hydrochloride  loaded electrospun  fibers  were  prepared  for  buccal  drug delivery  with  the  aim
of  improving  the  oral bioavailability  of the  crystalline  drug,  which  can be  achieved  by  the  increased solu-
bility  and  by  the  circumvention  of the  intensive  first  pass metabolism.  The  water  soluble hydroxypropyl
cellulose  (HPC)  was chosen  as  a mucoadhesive  polymer.  In  order to improve  the electrospinnability  of
HPC, the  also mucoadhesive  poly(vinyl alcohol)  (PVA) was used. During  the  experiments,  the  total  poly-
mer concentration  was kept  constantly  at  15%  (w/w),  and only  the  ratio of the  two  polymers  was changed.
Five different  HPC:PVA  ratios  (5:5,  6:4,  7:3,  8:2,  9:1)  were  examined.  Combination  of  rheological  mea-
surements  and  molar  reflectance  characterization  with  scanning  electron microscopy  was applied  for the
determination of the  optimum  composition  of the  gels  for  fiber formation.  The crystalline-amorphous
transition  of papaverine  hydrochloride  was  also  tracked by  Fourier transform  infrared  spectroscopy.  A
correlation  was found between the  macrostructural properties  of the  polymer  solutions and their  elec-
trospinnability  and  the  consequent  morphology  of the  resultant samples.  Along  with  the  changes of the
polymer  ratio, the  corresponding  morphology  of the  electrospun  samples  also varied.  With  decreasing
HPC ratio  of the  system, a transition  from the  spray-dried film-like  structure through  fibrous  film to
fibers  was observed.  Polymer  solutions of the  lowest elasticity and smallest intermolecular  interactions
contributed  to the  best fiber characteristics  of the  samples. The results enable  the  determination  of the
polymer  ratio  for  the  formation of applicable  quality  of electrospun  fibers. According  to the  results  5:5
and 6:4  polymer  ratios  enabled  the  best  fiber performance.
© 2017  Elsevier B.V.  All  rights  reserved.
1. Introduction
Cardiovascular diseases are among the leading causes of death
in the world. Cerebral ischaemia represents one of the major cardio-
vascular health concerns because of not only the morbidity but its
role in  the development of dementia and other disabilities. Consid-
ering the effect of cerebral ischaemia on overall public health, it is
obvious that proper management of such conditions is essential to
achieve the best possible outcome, therefore prompt and targeted
treatment can enormously contribute to  both public and individual
health [1].  However, pharmacodynamic properties of papaverine
are beneficial for the treatment of stroke; its unfavourable bio-
pharmaceutical behavior confines the clinical applicability. The
Abbreviations: HPC, hydroxypropyl cellulose; PVA, poly(vinyl alcohol).
∗ Corresponding author.
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benzylisoquinoline-type opium alkaloid papaverine (Fig. 1) has a
non-specific direct relaxant effect on smooth muscle. The vasodi-
lation is resulted by the inhibition of phosphodiesterase enzymes
and the direct actions on calcium channels [2].
Orally administered papaverine has been shown to increase
regional cerebral blood flow in  humans. Papaverine hydrochlo-
ride is  slightly soluble in water, and its poor peroral bioavailability
is  associated with high intra- and interindividual variability. This
variation can be explained by the extensive first pass metabolism
and the inadequate absorption depending on incomplete in vivo
drug release [3]. Furthermore, the utilization of alternative admin-
istration routes is  hastened by tha fact that papaverine has been
reported to carry the risk of potential liver damage [4,5].  As a  result
of these properties, papaverine can only be  administered parenter-
ally in emergency cases, such as cerebral ischemia in  order to  ensure
the therapeutic drug levels in the brain and the rapid onset. Since
the administration of invasive parenteral dosage forms has sev-
eral unfavourable features, these problems can be addressed by
http://dx.doi.org/10.1016/j.jpba.2017.02.030
0731-7085/© 2017 Elsevier B.V. All rights reserved.
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Fig. 1.  Chemical structure of papaverine hydrochloride.
using alternative dosage forms, such as inhalation or buccal, rectal
or transdermal administration routes [6].
Nanofibers have been successfully applied in  various fields of the
medicine, such as tissue engineering scaffolds, in wound healing,
vascular graft implants and drug delivery [7–9] because of their
pharmaceutically luring advantages, such as high surface area to
volume ratio and very high porosity [10,11].
Electrospinning represents the most commonly used fiber form-
ing technique, which utilizes electrical forces to produce nanofibers
from polymers [12].  Wide variety of polymers can be used to con-
trol the drug release kinetics or to modify the dissolution [13].  The
incorporation of poorly water-soluble drugs into polymer-based
nanofibers is  of special interest because of the increased solubility
and the consequent improved oral bioavailability. Such improve-
ment in the solid state properties can be enabled by the high
amorphization efficacy of the fiber forming process and by the
unique characteristics of the formed fibrous system [14–16].
The oral cavity is a  possible site for the delivery of drugs. With
the mucosal delivery local pharmacological effects can be achieved.
For this application, the residence time and the local drug concen-
tration are the most important factors, influencing the amount of
absorbed drug [17].  Systemic effects can also be achieved via trans-
mucosal routes, which is due to  the highly vascularized, rich blood
supplied and relatively permeable properties of the mucosa. Per-
meation and consequently the bioavailability can increase by using
enhancers (for example polysorbate, sodium lauryl sulfate) [18,19].
Because of the advantages provided by buccal formulations, such
as rapid onset of effect, good bioavailability, elimination of hep-
atic first-pass metabolism and consequently the reduced amount
of drug, the buccal delivery could be an alternative administration
of the parenteral routes [20–26].
Chemically-modified cellulose derivatives (ethers and esters)
are commonly used for buccal drug delivery [20].  The first genera-
tion of mucoadhesive polymers such as the hydroxypropyl cellulose
(HPC) and poly(vinyl-alcohol) (PVA) are able to form non-covalent
bonds with the mucosa, thus ensuring a  better oral residence and
drug release at the absorption site. HPC presents high mucoadhe-
sive potential and its further advantage is  the aqueous solubility,
thus avoiding the need of the use of organic solvents during
production [27–29].  Most of the natural and semisynthetic poly-
mers exhibit poor spinnability thus the application of polymer
of good spinnability could improve fiber forming capability. The
combination of two polymers enables adequate composite fiber
performance.
The fiber forming mechanism is very complex and the elec-
trospinnability of polymer gels is widely studied, but still not
completely understood. The surface tension, conductivity, entan-
glement concentration, viscosity and the dynamic moduli: storage
(G’) and loss (G”) modulus are the most commonly examined
properties. The conductivity measurement could be informative
when the polymer solutions containing ionogenic polymer in dif-
ferent concentrations and then the conductivity can correlate
with the polymer concentration. In case of the total mass of  the
uncharged polymers and the active pharmaceutical ingredients
are the same, the conductivity and the surface tension remain
unchanged [7,30–35].
Molar refraction was  successfully used to examine the
intermolecular forces between polymer and plasticizer [36]. Deter-
mination of molar refractions could be applied to examine the
interactions between the polymers. Best of our knowledge the
molar refraction effect on the fiber forming process has not  been
published yet.
The primary aim of the present study was to prepare papaverine
hydrochloride loaded buccal nanofibrous films, and to deter-
mine the optimum composition of HPC-PVA aqueous solutions for
electrospun fiber formation based on the rheological and molar
reflectance characterization of the system. With this formulation
intended for transmucosal drug administration, the unique prop-
erties of the nanofibrous sheets and the benefits of the buccal
formulation could be combined preferably.
2. Materials and methods
2.1. Materials
Hydroxypropyl cellulose (Klucel EXF Pharm, Ashland, USA;
Mw ∼ 80000; the moles of substitution =  3.8) and poly(vinyl alco-
hol) (18-88 Ph. Eur., Merck, Darmstadt, Germany) polymers,
polysorbate 20 (Ph. Eur., Molar chemicals, Hungary) and distilled
water were used for the preparation of gels. The model drug was
papaverine hydrochloride (Ph. Eur.).
2.2. Preparation of papaverine-HCl gels
Papaverine-HCl stock solution was  prepared by  dissolving 0.6 g
drug in  18.8 g of distilled water in the presence of 0.6  g polysorbate
20 (3% w/w) applying a  few minutes of heating. The clear solution
was cooled to room temperature and then it was diluted to 20.0 g
with distilled water. The gels were prepared by  the addition of  the
necessary amount of HPC, PVA and 30 mg/g papaverine-HCl aque-
ous stock solution. The total polymer concentration of the gels was
15% (w/w). The HPC: PVA mass ratios were 5:5, 6:4, 7:3, 8:2, 9:1
which corresponded to  7.5, 12.2, 10.5, 9 and 13.5 HPC concentra-
tion (% w/w), respectively with the final polymer concentration of
15% (w/w). The required amount of PVA and stock solution was
measured into a  beaker, than it was heated on 80–90 ◦C and stirred
on magnetic stir plate until a  homogenous gel was achieved. The
gels were cooled to the room temperature and finally the neces-
sary amount of the HPC was added and it was also stirred until
homogenous gel was achieved. The samples were stored at room
temperature (25 ± 2 ◦C).
2.3. Calculation of the molar refraction
The molar refraction values were calculated by  the Lorentz-
Lorenz equation [36]:
R  = Vm −  r (1)
where Vm is the molar volume (dm3mol−1) and r is  the space-filling
factor. Vm was calculated as
Vm = M/ (2)
where M is the molecular weight (g  mol−1) and  is the volumetric
mass density of the gels (g cm−3).
Density values were determined with calibrated flask method.
In case of molecular weight calculations, the mass ratios of  the
components (papaverine-HCl, polysorbate 20, PVA and HPC) were
considered.
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The space-filling factor (r), which denotes the fraction of the
molar volume actually occupied by the molecules [36],  is calculated
as
r = (n2 −  1)/(n2 + 2) (3)
where n is  the refractive index, which was determined at
22.6 ± 0.1 ◦C by  Krüss Refractometer (Germany).
2.4. Rheological properties of the gels
The rheological properties of the gels were carried out with
Kinexus Pro rheometer (Malvern Instruments Ltd, UK). Measured
data were registered with rSpace for Kinexus Pro 1.3  software.
Samples were measured using parallel plates geometry (50 mm
diameter) in constant 25 ± 0.1 ◦C temperature. The gap between
the plates was 0.0300 mm.
Storage and loss moduli were determined by oscillatory tests.
The elastic or storage modulus (G’), which represents the ability of
the materials to  store energy, was calculated as
G’ = (a/a)∗cosı
and the viscous or loss modulus (G”), which can be defined as
the ability of the material to  dissipate energy, was  calculated as
G′′ = (a/a)∗sinı,
where a is  the shear stress, a is  the deformation and ı is the phase
shift angle [37].
The oscillatory shear measurements were performed at ampli-
tude within the linear region which was chosen to  40% within the
viscoelastic region and the frequency was in the range of 0.1–10 s−1.
Three parallels were measured of each gel in  both tests.
2.5. Electrospinning
The prepared gels were transferred into plastic syringes and
then the syringes were vented. After all, a  metallic needle with
1.2 mm inner diameter was attached through a  silicon tube. The
syringe was put into a  syringe pump which provided the controlled
polymer gel flow.
The applied voltage was examined in  three levels: 20, 25 and
30 kV. The needle to  collector distance was 5, 10 and 15 cm.  The
flow rate was 0.2 or  0.3 ml/h. In the course of the 10 min  continuous
apparatus operation, the fibers were collected on aluminum foil.
2.6. Fourier transform infrared (FT-IR) spectroscopy
Physicochemical properties of the fibers were examined using
Jasco FT/IR-4200 spectrophotometer which was equipped with
Jasco ATR PRO470-H single reflection accessory. The measurements
were performed in absorbance mode. The spectra were collected
over a  wavenumber range of 4000 and 1800 cm−1. After 50 scans,
the measurements were evaluated with the FT-IR software (Spectra
Manager-II, Jasco).
2.7. Preparation of physical mixtures
Physical mixtures of the components of the drug loaded
nanofiber in  the same concentration were made by  the manual
combination of papaverine-HCl, PVA and HPC in a  pestle and mor-
tar. After the PVA was milled, the substance was homogenized. The
mixture was used as control for the FT-IR examinations.
Table 1
The measured (Rm) and the calculated (Rc) molar refractions, the space-filling factors




r Rm Rc (Rm-Rc)/Rm*100
5:5 0.2224 75.2288 75.2392 −0.0139
6:4  0.2223 71.6466 71.6357 0.0153
7:3  0.2223 67.9983 68.0322 −0.0498
8:2  0.2225 64.5054 64.4286 0.1191
9:1  0.2225 60.7817 60.8251 −0.0714
Fig. 2. Lorentz-Lorenz plot values of papaverine-HCl loaded gels (Rm is a  measured-
and Rc is a  calculated molar refraction index).
2.8. Scanning electronmicroscopic analysis (SEM)
Detailed morphology of the fibers was  characterized by scan-
ning electron microscope (SEM). SEM studies were performed by  a
Hitachi S-4300 instrument equipped with a  Bruker energy disper-
sive X-ray spectroscope (Hitachi Science Systems, Ltd., Japan). The
surfaces of samples were covered by a sputtered gold conductive
layer, and 5–10 kV accelerating voltage was used for taking high
resolution electron micrographs.
3. Results
3.1. The Lorentz-Lorenz analysis
Density and refractive index were determined in  case of each
gels. Rm values and space-filling factors were calculated using Eqs.
(1 and 3), respectively. Rm values were plotted as a  function of
PVA concentrations (% w/w) and a  linear was fitted. The slope of
linear regression was  2.4024 and the linear regression accuracy
values (R2) was 0.9999. According to the regression lines, Rc values
were calculated. Table 1 summarizes the measured (Rm) and the
calculated (Rc)  molar refractions, the space-filling factors and the
Lorentz-Lorenz plot (Rm-Rc)/Rm values (%). The nearly unchanged
space-filling factor values refer to  almost equal molecular mobil-
ity. Lorentz-Lorenz plot values of the papaverine-HCl loaded gels
as function of HPC:PVA mass ratio are shown in  Fig. 2.  According
to the results, along with increasing HPC ratio, Rm and Rc values
are continuously decreasing, which indicates the lack of  specific
intermolecular interaction between the polymers. However, the
divergence, which is the highest in case of HPC:PVA 8:2, 9:1 and 7:3
mass ratio, indicates slight, non-specific intermolecular interaction
e.g hydrogen bonding or altered chain entanglement.
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Fig. 3. Ratio of storage (G’)  and loss (G”) moduli of papaverine-HCl loaded gels as a
function of HPC:PVA mass ratio (dynamic moduli measured at a  frequency 1.995 Hz).
3.2. Rheological measurements
The viscoelasticity of gels influences the jet formation and the
jet stability, so it is  one of the most critical parameters for the
successful electrospinning process. Oscillatory test was  used to
determine the storage and loss moduli. The tests were compared at
different frequency values. The results of G”/G’ values displayed the
same tendency at the different frequency values, therefore only the
results corresponding to 1.998 s−1 value were presented in Fig. 3.
A local minimum was observed in the dynamic modulus ratio
of HPC:PVA = 8:2 sample. The modulus ratio decreases monoton-
ically reaching a  minimum value and following the increase. The
smallest ratio refers to the most elastic behavior of the composite
gel compare to the other HPC:PVA ratios. The latter suggests that
the preponderant viscoelasticity of the sample could be  disadvanta-
geous from the point of fiber formation, since the electrical forces
cannot be effectively transferred to  the viscoelastic elongation of
the polymer jets in the course of the fiber formation.
3.3. Morphology study of the samples
The electrospinning of papaverine-HCl containing gels resulted
in a well-defined, more or less round shaped samples on the alu-
minum foil. Most of the prepared samples could be easily peeled off
from the aluminum foil, which is beneficial for the further studies
and also for the final applications. Only the sample of HPC:PVA 9:1
mass ratio was the exception, since the firm adhesion inhibited its
removal.
The morphology of the prepared samples was tracked by SEM
measurements. The results indicate that with increasing HPC ratio
to PVA the morphology was changed; transition from spray-dried
film-like structures through fibrous films to fibers can be observed
which is illustrated by Fig. 4.
Partially spray-dried films and beaded fibers were formed in
case of HPC:PVA 9:1 mass ratio, which can be observed in Fig. 4E.
The simultaneous electrostatic spraying and electrospinning of the
viscous polymer solution resulted in the appearance of films and
beaded fibers.
In case of 8:2 ratio, a  fibrous film morphology can be observed
(Fig. 4D), while at 7:3 ratio also the fibrous film formation is
dominant (Fig. 4C), but in the latter case the fibrous structure
characterizes the whole sample. At 5:5 and 6:4 HPC:PVA mass
ratio (Fig. 4A and B)  clearly fibrous systems, without beads can be
observed.
Fig. 4. SEM photos of the  spray-dried film-to-fiber transition as a  function of
HPC:PVA mass ratio 5:5 (A), 6:4 (B), 7:3 (C), 8:2 (D), 9:1 (E).
(The total polymer concentration was  15% (w/w). During the fiber forming pro-
cess  30 kV voltage was applied. The flow rate was 0.2  ml/h and needle to  collector
distance was 15 cm.)
With the decreasing HPC ratio the fibrous morphology will
become the dominant feature. The transition from film forma-
tion to  the mainly fibrous system is  initiated at 8:2 mass ratio
and completed by 6:4 ratio. Along with the decrease of HPC ratio
the proportion of the fibrous parts in the electrospun samples
increased.
3.4. FT-IR analysis
The FT-IR spectra of various samples, physical mixture and
the components are presented in  Fig. 5.  The characteristic peak
of the model drug around at 2300–2700 cm−1 can be observed
clearly in the physical mixture. Another characteristic peaks of
the papaverine-HCl were overlapped with peaks from functional
group of the polymers, so that to  verify the amorphous transition of
the drug the 2300–2700 cm−1 wavenumber range was evaluated.
In contrast to crystalline materials, where the limited rotational-
vibrational transitions are allowed, in  amorphous materials several
transitions can take place. Since the absorbed energy is  dissipated
among the numerous transitions, broadening and merging of the
spectrum is a  common phenomenon as a  result of crystalline-
amorphous transition.
The lack of the high intensity characteristic peaks of  various fiber
samples indicates that the papaverine-HCl was incorporated into
the nanofibers in  an amorphous state as a  result of the electrospin-
ning process.
4. Discussion
There is a desired chain entanglement density, which is  nec-
essary to produce electrospun fibers [30]. The optimal change
entanglement, where overlapping of polymeric chains renders a
flexible supramolecular structure to the gels, is developed at a  given
concentration range resulting in  good fiber forming properties.
If the chain entanglement become too extensive, in other words
unfavourable overlapping of polymeric chains takes place, instead
of the formation of defect-free individual fibers the fibrous film for-
mation is  dominant. Alteration of polymeric chain entanglement,
thus the change of polymeric chain overlapping can be explained
by the obtained results, since molar reflectance and rheological
parameters also depend on the inter- and intrachain interaction
of polymers. The molar reflectance characterization results indi-
cated that the increase in HPC content resulted in  the enhanced
entanglements of polymer chains, which is disadvantageous in  the
course of the fiber forming process. Generally, spinnable solutions
should exhibit viscoelastic properties, but the too high elasticity is
objectionable during the fiber forming process. In the case of  the
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Fig. 5. FTIR spectra of papaverine-HCl (a), hydroxypropyl cellulose (HPC) (b),
poly(vinyl alcohol) (PVA) (c), polysorbate 20 (d), physical mixture (e), fibers
(f–j):15% (w/w) polymer, 3% (w/w) polysorbate 20, 30 kV voltage, 15 cm distance,
0.2  ml/h flow rate between 4000 and 1800 cm−1 wavenumber.
(HPC:PVA = 5:5 (f), HPC:PVA =  6:4 (g), HPC:PVA = 7:3 (h), HPC:PVA = 8:2 (i),
HPC:PVA =  9:1(j)).
most elastic behavior (smallest G”/G’ ratio) of  the polymeric solu-
tion the film formation was the dominant process, while the less
elastic behavior of the samples resulted in more fibrous structure.
The observed phenomenon is in good agreement with the authors’
previous studies, where the adhesiveness and the viscosity values
had a local minimum, which could lead to  higher productivity of
the fiber formation process and optimum micromorphology of the
emitted fibers [38].
5. Conclusion
Papaverine-HCl loaded HPC-PVA composite nanofibrous sys-
tems were prepared successfully by electrospinning process. The
optimum composition of HPC-PVA fibers was  determined based
on the rheological and molar reflectance characterization of  their
solution.
This formulation could enable the transmucosal amorphous
drug delivery, thus improving the oral bioavailability of  the poorly
soluble crystalline papaverine-HCl, meanwhile avoiding its first
pass metabolism.
Appendix A. Supplementary data
Supplementary data associated with this article can be  found, in
the online version, at http://dx.doi.org/10.1016/j.jpba.2017.02.030.
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a  b  s  t  r a  c t
Electrospun  papaverine  hydrochloride-loaded  nanofibrous  sheets consist  of hydroxypropyl  cellu-
lose/poly(vinyl alcohol)  composite  were  prepared for  buccal  administration  for  cerebral ischemia. The
nanofibrous  drug  delivery  system was subjected  to accelerated  stability  test for four  weeks  in order  to
scrutinize  the  solid  state  changes  relating to  the  stress  induced  (40 ± 2 ◦C/75 ± 5%  relative humidity)  phys-
ical ageing. Micro-  and macrostructural  alterations were  detected  using  scanning  electron  microscopy
(SEM),  Raman  spectroscopy,  Fourier  transform infrared  spectroscopy  (FTIR)  and  positron  annihilation
lifetime  spectroscopy  (PALS). Significant  changes  were  revealed  at  both  supramolecular  and  macroscopic
levels.  Microscopic  morphology  uncovered  major morphological  transitions.  Subtle  variations  of Raman
and  FTIR spectra indicated  that the local chemical  environment of papaverine  was altered  suggesting  a
partial phase transition  of the  active.  Discrete  o-Ps  lifetimes and lifetime-distributions  unveiled a two-
step  ageing  process of the  drug  carrier.  In  addition  to the  tracking of the  glassy-to-rubbery  transition
of the  fiber  forming polymers,  the  Raman  spectroscopy  enabled  monitoring  the  kinetics  of  the  phase
transition observed.
© 2017  Elsevier  B.V.  All rights  reserved.
1. Introduction
The opium alkaloid papaverine exerts a  non-specific direct
relaxant effect on smooth muscles, including the dilatation of blood
vessels [1]. These pharmacodynamic properties make it a  potential
candidate for the treatment of cerebral ischaemia, but its unpleas-
ant physicochemical and biopharmaceutical properties (such as
slight water solubility, poor peroral bioavailability, high pharma-
cokinetic intra- and interindividual variability) restrict the per os
administration [2,3]. These unfavourable features can be addressed
with the combination of a  nanofibrous and a  buccal formulation.
The former targets the solubility related issues, whilst the latter
aims at the concerns associated with first pass metabolism and the
consequential oral bioavailability. The rapid onset of effect and the
Abbreviations: FTIR spectroscopy, Fourier transform infrared spectroscopy; HPC,
hydroxypropyl cellulose; o-Ps, ortho-positronium; PVA, poly(vinyl alcohol); PALS,
positron annihilation lifetime spectroscopy; SEM, scanning electronmicroscopy.
∗ Corresponding author.
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reduced inter-and intraindividual varieties are also representing
the favourable expectations of this formulation [4,5].
In our previous study, hydroxypropyl cellulose (HPC)- and
polyvinyl alcohol (PVA) based papaverine hydrochloride loaded
nanofibrous sheets were prepared for buccal application. During
the preformulation study the ratio of the two  polymer was varied
(HPC:PVA =  5:5, 6:4, 7:3, 8:2, 9:1) and the total polymer concen-
tration was kept constantly at 15% (w/w). HPC:PVA 6:4 composite
mass ratio resulted the best fiber forming characteristics [6],  so in
the following, only this sample ratio was  examined. Fourier trans-
form infrared (FTIR) measurements suggested that the drug went
through a  solid state phase transition (presumably crystalline-
amorphous transition) as a result of the electrospinning process.
Although, amorphous form represent an effective means of disso-
lution enhancement, the thermodynamically metastable nature of
such systems is a  real headache for researchers [7]. High enthalpy
of amorphous materials is  considered as the main reason for spon-
taneous transition into a  lower enthalpy correspondent crystalline
form. Such transitions can be efficiently tracked by volume- and
enthalpy relaxation measurements [8,9].  The amorphous polymers
might undergo physical ageing, which can be accompanied with
http://dx.doi.org/10.1016/j.jpba.2017.05.035
0731-7085/© 2017 Elsevier B.V. All rights reserved.
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Fig. 1. SEM morphology of the freshly prepared (A) and the stored samples (week 1(B), week 2 (C), week 3 (D), week 4  (E)).
supramolecular changes in  the polymers. The moisture- and CO2
absorption from the surrounding air is  one of the possible expla-
nations for this phenomenon [10,11].  It has been well documented
that solid dispersions possess higher physical stability than that of
the raw amorphous material itself. The possibilities for the forma-
tion of drug-polymer interactions (e.g hydrogen-bond formation)
decrease the recrystallization tendency of amorphous actives [12].
The supramolecular structure and the solid state characteristics
of a polymeric drug delivery system influence the drug release char-
acteristics, which have a major impact on peroral bioavailability.
The monitoring of the solid state stability and the supramolecular
changes of the amorphous drug loaded polymer-based nanofibrous
system is  of special interest, since these are crucial factors from the
point of long term stability [13].
The different types of solid state characterization methods can
be classified in three groups: imaging techniques (e.g. scanning
electron microscopy (SEM) and atomic force microscopy (AFM)),
macrostructural (e.g. FTIR spectroscopy, Raman spectroscopy, dif-
ferential scanning calorimetry (DSC) and power X-ray diffraction
(PXRD)) and microstructural (e.g. positron lifetime spectroscopy
(PALS), solid-state nuclear magnetic resonance (ssNMR)) charac-
terization methods [13].  The ssNMR is  very sensitive to molecular
conformation in solid-state systems, but with this technique
the free volumes remain invisible [14–18].  PALS is  a  sensitive
method to  determine size distribution of free volume holes through
ortho-positronium (o-Ps) lifetime distributions, which is in  strong
correlation with the physical ageing of the polymers [10,19–21].
The aim of the present study was to monitor the supramolecular
changes of the papaverine-HCl-loaded hydroxypropyl cellulose-
poly(vinyl alcohol) nanofibrous system, through positronium
lifetime distribution and tracking the physical stability of the deliv-
ery system with FTIR and Raman spectroscopy in the course of the
four weeks long storage under stress condition.
2. Materials and methods
2.1. Materials
For the fiber forming process hydroxypropyl cellulose (Klucel
EXF Pharm, Ashland, USA; Mw ∼80000; the moles of substitu-
tion =  3.8), poly(vinyl alcohol) (18–88 Ph. Eur., Merck, Darmstadt,
Germany) and polysorbate 20 (Ph. Eur., Molar chemicals, Hungary)
were used. The active pharmaceutical ingredient was  papaverine
hydrochloride (Ph. Eur.).
2.2. Fiber preparation
Papaverine-HCl containing gel of 15% (w/w) total polymer
concentration and HPC: PVA 6:4 mass ratio, was prepared by
the addition of the necessary amount of HPC, PVA and 30 mg/g
papaverine-HCl aqueous stock solution (according to  [6]) apply-
ing gentle heat and magnetic stirring. The gel was then transferred
into a  plastic syringe equipped with a  metallic needle (1.2 mm
inner diameter). In our previously published paper the effect of
the applied voltage and the needle to collector distance on the
fibers morphology was studied. The applied voltage was examined
in three levels: 20, 25 and 30 kV. The needle to  collector distance
was 5, 10 and 15 cm.  The best fiber characteristics were achieved
in case of 15 cm distance and better fiber characteristic was found
with the increasing voltage.
So that, for the electrospinning process the voltage was set to
30 kV. The distance between the spinneret and the collector was
15 cm.  The fibers were collected on aluminum foil in the course of
the 45 min  spinning duration.
2.3. Storage conditions
The accelerated stability test was  done based on the standard
protocol to  follow the quality changes of the product and deter-
mine recommended storage conditions. The nanofibrous samples
were stored in closed containers at 40 ± 2 ◦C and 75  ±  5% relative
humidity for four weeks.
2.4. Scanning electron microscopic analysis (SEM)
The morphology changes of the nanofibrous systems were fol-
lowed with scanning electron microscope (SEM). SEM studies were
performed by a  Hitachi S-4300 instrument equipped with a Bruker
energy dispersive X-ray spectroscope (Hitachi Science Systems,
Ltd., Japan). The surfaces of samples were covered by  a sputtered
DOI:10.14753/SE.2020.2446
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gold conductive layer, and 5–10 kV accelerating voltage was used
for taking high resolution electron micrographs.
2.5. Fourier transform infrared (FTIR) spectroscopy
Physicochemical properties of the fibers were examined using
Jasco FT/IR-4200 spectrophotometer which was equipped with
Jasco ATR PRO470-H single reflection accessory. The measurements
were performed in  absorbance mode and spectra were collected
over a wavenumber range of 4000 and 1800 cm−1. 100 scans were
performed at a  resolution of 2 cm−1. The measurements were eval-
uated with the FTIR software (Spectra Manager-II, Jasco).
2.6. Raman spectroscopy
The MI-Raman spectra were recorded by  a FRA 106 extension
of a Bruker IFS 55 Fourier-transform infrared (FT-IR) spectrome-
ter using a  100 mW  1064 nm Nd:YAG laser and a  liquid nitrogen
cooled Ge detector. The MI-Raman spectra were recorded at 2 cm−1
instrumental resolution and 512 scans were accumulated.
2.7. Positron annihilation lifetime spectroscopy (PALS)
For positron lifetime measurements, a  positron source made of
carrier-free 22NaCl was used. Its activity was around 106 Bq and
the active material was sealed between two very thin Kapton
®
foils.
The source was put between two layers of nanofibrous sheets which
were peeled off from the aluminum foil. Lifetime spectra were mea-
sured with a  fast–fast coincidence system based on BaF2/XP2020Q
detectors and Ortec
®
electronics. Three parallel spectra were mea-
sured from each sample.
Firstly, the spectra were evaluated by the RESOLUTION com-
puter code. Three lifetime components were found in all samples,
where the longest component was identified as o-Ps lifetime. The
MELT code was used to  extract lifetime distributions from the spec-
tra [22,23]. These latter evaluations were used to characterize the
size distribution of the free-volume holes in the samples through-
out the o-Ps lifetime [10].
3. Results and discussion
3.1. Morphology study of the samples
SEM images are summarized in Fig. 1 indicating a  time depen-
dent progression in the morphology. However, the basic fibrous
structure was retained by  the end of the stability test, significant
structural changes can be  observed. Stress induced deterioration
of fibrous structure can be divided in two major steps. At  first, a
fiber-film like transition was commenced, which was manifested
in the merging and broadening of individual fibers. After all, frag-
mentation took place, i.e. tenuous initiative scraps were formed.
Furthermore, signs of surface crystallization of the active could also
be noticed.
Previous works suggested that one of the possible reasons for
the film formation could be  the glassy-to-rubbery transition of the
polymeric carriers. This alteration could be the consequence of the
plasticization effect of the polysorbate 20 and also the elevated
temperature during the storage. The moisture absorbed from the
environment acts also as a  plasticizer leading to significant decrease
of the Tg of the fiber-forming polymers [10,24],  but since the sam-
ples stored in airtight containers, the latter effect can be neglected.
3.2. FT-IR analysis
Fig. 2 shows the FTIR spectra of papaverine-HCl loaded nanofi-
brous sheets as a  function of storage time. In the case of the
Fig. 2.  FTIR spectra of the components and the stored samples.
fresh fibrous sample, the lack of high intensity characteristic peak
of papaverine-HCl around at 2500 cm−1 is obvious. The broad-
ening and merging of the spectrum could refer to the physical
state related changes of the active, conceivably to a  crystalline-
amorphous transition.
After one week of storage, a peak appeared at 2500 cm−1 related
possibly to  the active which was  persistent throughout the remain-
ing sampling points. It  should be  noted that the relative peak
intensity was almost constant in all cases. It can be inferred that
the latter phenomenon is  the consequence of the recrystallization
of the active material. This is  in  accordance with the observations
of the morphological evaluation.
Elevated temperature and exposition to  high humidity have
a substantial impact on molecular mobility and secondary
intermolecular interactions, notably increasing the former and
decreasing the latter. These changes can make a  drug delivery
system more prone to  solid state modifications, and the escala-
tion of the molecular mobility sharply boosts the chances that
molecules or clusters of amorphous actives start to form crystals.
In our preliminary study, we demonstrated that there only weak
DOI:10.14753/SE.2020.2446
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Fig. 3. Raman spectra of the samples between 400 and 3500 cm−1.
secondary inter- and intramolecular interactions existed between
the polymers, which also confirm that even a subtle elevation of
temperature can be sufficient to  overcome these attractive forces.
Although, the presence of weak secondary interactions is consid-
ered beneficial from the point of fiber formation, because optimum
molecular entanglement can be achieved, but, on the other hand,
this can be a drawback for the solid state stability, since these inter-
actions are not strong enough to keep the active in an amorphous
state.
3.3. Raman spectroscopy
Vibrational characterization of the samples is  represented in
Figs. 3 and 4.  As seen in Fig. 3,  characteristic peaks of the active
are well recognizable in the spectrum of the physical mixture
suggesting the active being in  a  crystalline state. Considering the
spectrum of fresh samples, significant merging can be observed,
but the spectra of the stored samples underwent a progressive
evolution until a spectrum resembling the physical mixture was
achieved, which refers to a time-dependent process. Significant
peak shifts were only observed in the CH-stretching vibrations
of papaverine-HCl around 2938 cm−1. The observed peak shifts,
were as follows: week 0: −4.9 cm−1,  week 1: −1.9 cm−1, week 2:
−2.9 cm−1,  week 3: −2.9 cm−1 and week 4: −2.9 cm−1.  Taking a
closer look at the region of 50–200 cm−1 assigned as lattice vibra-
tion, a  time-dependent process emerges strongly relating to  the
solid state changes of the drug loaded polymeric systems. As rep-
resented in Fig. 5A and B the shape and the integrated area of
the designated region increasingly approximate the characteris-
tics of the physical mixture, suggesting that recrystallization of
Fig. 4. Raman spectra of the samples between 400 and 800 cm−1.
papaverine took place as a  result of the stress conditions. Simi-
larly, characteristic peaks in the region between 700 and 780 cm−1
attributed to  the benzene and isoquinoline ring out of  plane defor-
mation and the C C C bond (connecting the two ring systems)
deformation merged into the baseline and then re-separation of
these peaks was noticeable. This was  also noticeable in the region
between 430 and 700 cm−1,  where peaks of  the wagging vibra-
tions of methoxy moieties (463 cm−1 and 473 cm−1), out of  plane
deformations of the rings (533 cm−1,  563 cm−1), in plane and out of
pane deformations of the rings and twisting vibrations of  methoxy
moieties (647 and 662 cm−1,  respectively) can be found (Fig. 4)
[25]. This phenomenon can be explained by  the limited confor-
mational and molecular mobility of the moieties and the active in
a crystalline form, which led to  sharp characteristics peak. In an
amorphous state, the energy is distributed between the numerous
allowed conformations resulting the merging and broadening of
the peaks.
3.4. PALS measurements
Fig. 6 illustrates the average discrete o-Ps lifetimes as a function
of  storage time indicating a  two-step process in  supramolecu-
lar restructuring. At  first, one week exposition to  stress condition
resulted in the increase of the o-Ps lifetime value and, consequently,
larger free volume holes. This was followed by a  sharp drop and
then a  successive marked rise of o-Ps lifetime values. Distributions
of o-Ps lifetimes also confirm the two-step ageing process, suggest-
ing multiple supramolecular restructuring throughout the stability
test (Fig. 7). The first storage week induced a  pronounced change in
the distribution in terms of the width as well in the average values.
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Fig. 5. The shape (A) and the integrated area [26]  (B)  of the region between 50 and 200 cm−1.
Fig. 6. Average discrete o-Ps lifetimes of the nanofibers as a  function of storage time.
This process was pursued by a  second rearrangement, as indicated
by the backward shift and narrowing of the distributions.
These observations can be traced back to several reasons includ-
ing the phase transition and redistribution of the active ingredient,
the supramolecular rearrangement of polymeric chains and final
fragmentation of the fibers. After 1 week, the elevated temperature
during the storage increased the molecular mobility of polymer
chains thus destroying the original polymeric structure and creat-
ing new vacancies (t1). Similarly, the reduction in  the intensity of
the lattice vibrations shown in Fig. 5b also refers to  the enhanced
molecular mobility of the active, which leads to enthalpy relaxation
by recrystallization.
However, later on (after 2 weeks), a  new structure was  formed,
possibly involving hydrogen bonds between the polymeric chains.
During storage, the peak at 1.951 ns, indicative of o-Ps atoms sit-
uated in holes between polymeric chains, shifted towards longer
lifetimes (o-Ps =  2.038 ns after 1 week), demonstrating the relax-
ation of the structure and the increase of free volume holes in  size.
This was most probably due to the storage under stress conditions
resulting in  the glassy-to-rubbery transition of the polymer fibers.
This transition can be tracked clearly on the SEM photos.
A longer exposure of fibers to elevated temperature leads to dif-
ferent structures in samples stored for 2–4 weeks. The temperature
driven mobility increase does not possess enough strength to  over-
power the binding force of hydrogen bonds between the chains.
Fig. 7. The  o-Ps lifetime distributions in papaverine-HCl-loaded nanofibrous system
after 0, 1,  2, 3, 4 weeks of storage (t0, t1,  t2,  t3,  t4).
The result is an intermediate structure: the size distribution of  free
volume holes widens but does not shift towards larger holes (t1-t3).
The widening of the distribution after 4 weeks of storage suggests
that a  large fraction of “crosslinks” was ruined by  the enhanced
molecular mobility and the crystallization of the papaverine caused
inhomogeneity in the free volume size distributions.
4. Conclusions
The combination of non-invasive spectroscopic methods –  FTIR,
Raman spectroscopy and PALS –, enable sensitive means for the
detection and the prediction of possible supramolecular interac-
tions initiated by stress conditions during storage. The applied
experimental setup represented a useful approach to track how the
ageing of the polymeric carrier reflected in the solid-state changes
of the active. The latter could be  of impact from the point of  the
physical stability of polymer-based drug delivery systems.
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Positron Annihilation Lifetime Spectroscopy
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Solid-state magic angle spinning (MAS)
Gel-film transition
Electrospun nanofibers
A B S T R A C T
Papaverine hydrochloride loaded gels, films and electrospun fibers were prepared for buccal drug delivery with
the aim of improving the oral bioavailability of the crystalline drug, which can be achieved by the increased
solubility and by the circumvention of the intensive first pass metabolism. The water soluble hydroxypropyl
cellulose (HPC) was chosen as a mucoadhesive polymer. In order to improve the electrospinnability of HPC, the
similarly mucoadhesive poly(vinyl alcohol) (PVA) was used. Since the drying of gels is of decisive role in either
the formation of drug-loaded cast films or electrospun fibers, a real time ortho-positronium (o-Ps) tracking of
gels was applied in order to obtain information about the supramolecular changes of the drying-induced gel-film
transition. An anomalous increase of o-Ps lifetime value in the gel-film transition region was observed which
refers to the remaining intramolecularly bound water in the drug-loaded polymeric gel matrix. The latter could
provide information about the characteristics of polymer-water interactions in the phase transition, conse-
quently the storage stability of the formulated solid system.
1. Introduction
The vast majority of newly developed drugs are poorly water so-
luble. If the drug is a part of dispersion system, it may exist as an
amorphous solid in polymeric system which enables improved solubi-
lity and dissolution rate compared to the crystalline form (Horvat et al.,
2018). Solubility and dissolution rate enhancements are generally ac-
cepted as a useful ways for the formulation of pharmaceuticals involved
in biopharmaceutical drug classification system (BCS) class II, where
oral bioavailability is confined by the limited aqueous solubility (Nagy
et al., 2012; Nagy et al., 2010).
During the past decade, several studies have been dealing with this
issue, most of them using solid dispersions. Recently, an increasing
interest has been paid to polymeric micro- and nanofibers as potential
drug delivery systems owing to their high specific surface area, high
porosity, and the ability to incorporate pharmaceuticals in amorphous
state (Szabó et al., 2015).
Gel polymers including various polysaccharides have been ex-
tensively studied for the development of drug delivery systems. Due to
their properties, such as bioavailability, biodegradability, stability,
availability, renewability, low toxicity, they can be applied as
independent solid matrices in different forms, e.g., micro- or nanofi-
bers. Their functionality-related properties are affected by the polymer
structure, the plasticizer concentration, the solvent and some other
factors related to dissolution, permeability and diffusion properties of
the film. Gels are formed by crosslinking polymer chains through
physical, ionic or covalent interactions and are well known for their
ability to absorb water. In the course of the formulation of solid dosage
forms, drying of the gels is necessary to eliminate excess solvent from
the gel structure. As the solvent is removed from the polymer solution,
the structure of the polymer may change dramatically, for example,
from randomly dissolved polycrystalline structures or from colloidal
dispersion to continuous film (Davidovich-Pinhas and Bianco-Peled,
2010; Sriamornsak and Kennedy, 2008; Szabó et al., 2012).
The main factors determining the drug release properties of a do-
sage form based on a hydrophilic polymer are the swellability and
erosibility of the polymeric matrix, as well as, the diffusibility of drug
molecules in the matrix (Borgquist et al., 2006). Swellability and the
erosibility of the matrix depend on the hydration tendency of the
polymer and the interaction between the polymer and the embedded
drug and the water molecules. In the case of amorphous or partly
amorphous drugs and polymers, this latter property can strongly be
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influenced by a phenomenon known as physical ageing. As the con-
stituents of the dosage form are usually not in equilibrium below their
glass transition temperature, usually undergo spontaneous, although
slow, transformations towards low-energy equilibrium states. The nat-
ural humidity of air initiates these processes and the plasticization ef-
fects of water, CO2 or other excipients are enough to change the crys-
tallinity of the polymer and the embedded drug (Süvegh and Zelkó,
2002; Szente et al., 2011).
The authors developed a real time method that can provide mole-
cular level understanding of gel-film transition of polymers based on
the o-Ps lifetime changes (Szabó et al., 2012). The latter enabled the
exact detection of the transition from a polymer-in-water system to a
water-in-polymer system and the determination of the end point of the
process of film forming. In the present study the same real time o-Ps
tracking of polymer gels was applied in order to obtain information
about the supramolecular changes of the gel-film or gel-fiber transition
in the course of drying. The latter could provide information about the
characteristics of polymer-water interactions in the phase transition,
which has a decisive impact on the storage stability of the formulated
solid system.
The aim of this work was to show and study the effects of different
formulation processes (film and fiber forming) on the morphology of
papaverine in gel matrix. To gain a detailed picture of these effects, we
have combined several structural characterization methods for the in-
vestigation of fibers and films.
2. Materials and methods
2.1. Materials
For the fiber forming process, hydroxypropyl cellulose (Klucel EXF
Pharm, Ashland, USA; Mw ~80,000; the moles of substitution=3.8),
poly(vinyl alcohol) (18-88 Ph. Eur., Merck, Darmstadt, Germany) and
polysorbate 20 (Ph. Eur., Molar chemicals, Hungary) were used. The
active pharmaceutical ingredient was papaverine hydrochloride (Ph.
Eur.).
2.2. Papaverine-HCl containing gel and fiber preparation
Papaverine-HCl containing gels of 15% (w/w) total polymer con-
centration and HPC: PVA 5:5, 6:4, 7:3, 8:2 mass ratios, were prepared
by the addition of the necessary amounts of HPC, PVA and 30mg/g
papaverine-HCl aqueous stock solution (according to (Kazsoki et al.,
2017a; Kazsoki et al., 2017b)) applying gentle heat and magnetic stir-
ring. The freshly prepared gels were then transferred into a plastic
syringe equipped with a metallic needle (1.2 mm inner diameter). In
our previously published paper the effect of the applied voltage and the
needle to collector distance on the fibers morphology was studied. The
applied voltage was examined in three levels: 20, 25 and 30 kV. The
needle to collector distance was 5, 10 and 15 cm. The best fiber char-
acteristics were achieved in case of 15 cm distance and 30 kV voltage
(Kazsoki et al., 2017b). The fibers were collected on aluminum foil in
the course of the 45minute spinning duration.
2.3. o-Ps lifetime measurement setup and design
For positron lifetime measurements, a positron source made of
carrier-free 22NaCl was used. Its activity was around 105 Bq and the
active material was sealed between two very thin kapton foils. Lifetime
spectra were measured with a fast-fast coincidence system (MacKenzie,
1983) based on BaF2/XP2020Q detectors and Ortec electronics. Every
spectrum was recorded in 4096 channels of an analyzer card and each
contained 105 coincidence events. The number of coincidence counts
was much lower than normally. This was inevitable because of the re-
quirements of the continuous real-time measurement. However, since
we needed only the o Ps lifetime as observable quantity, the low count
number has not increased the uncertainty of measurements beyond
reasonable levels.
The detectors were arranged vertically in this experimental setup,
which was previously published (Szabó et al., 2012). The upper de-
tector was, at beginning of the measurement, over the surface of the
polymer gel of 5mm. An aluminum plate was placed on the lower
detector. The positron source was placed on the plate and the gel-filled
glass cylinder was put on the source. Although a great number of po-
sitrons were lost for the Al plate in this arrangement, the significant
signal remained intact. As aluminum does not produce an o-Ps com-
ponent, any signal in that certain lifetime range came from the gel.
Although more than 50% of positrons annihilated in the aluminum
plate and the foil covering the glass cylinder, o-Ps signals came ex-
clusively from the gel. During the drying period (temperature:
22 ± 0.5 °C; relative humidity: 47 ± 3%) 12 parallel spectra were
collected in every day. The fitting parameter (variance of the fit, chi
square per degrees of freedom) is changing within 1.0 to 1.15 intervals
in each parallel measurement. From the point of the comparison of
samples these changes did not cause any artefact. All the lifetime
spectra were evaluated individually by the RESOLUTION computer
code (Kirkegaard et al., 1981).
2.4. Solid state magic nuclear magnetic resonance (NMR) measurement
Solid-state magic angle spinning (MAS) spectra of samples were
recorded on a Varian NMR system operating at a 1H frequency of
400MHz (100MHz for 13C) with a Chemagnetics 4.0 mm narrow-bore
double resonance T3 probe. The spinning rate of the rotor was 10 kHz
in all cases. For the one-dimensional 13C CP MAS (cross-polarization
magic angle), 2000 transients were recorded with SPINAL-64 decou-
pling with a strength of 83 kHz and 1ms of contact time. A recycle
delay of 30 s was used for all experiments, which is 5 times larger than
T1H of the crystalline papaverine-HCl. The temperature of all the
measurements was 20 °C. Adamantane was used as external chemical
shift reference (38.55 and 29.50 ppm). The 90° pulse lengths were 3 μs
for both the proton and the carbon channels for all the NMR experi-
ments.
3. Results and discussion
Fig. 1 (blue line) illustrates the drying curve of the HPC:PVA gels of
6:4 ratio which was considered the best from the point of view of its
spinning ability for the electrospinning process, and the corresponding
o-Ps lifetime values as a function of drying time (black line). The
comparison of the two curves is interesting, since the microstructural
changes of the gel-film transition can be clearly tracked. The evapora-
tion of the surface water content (linear phase of the drying curve) does
not visibly affect o-Ps lifetime values (Fig. 1) and the corresponding free
volumes of the polymer gel. The drying curve and the corresponding o-
Ps lifetime values clearly illustrate that there is a shift between the loss
of water and the consequent free volume decrease. The higher o-Ps
lifetime values enable the sufficient mobility of the polymer chains to
let the water diffuse out from the free volume holes. Most of the water
evaporates in this linear part of the drying curve; meanwhile the o-Ps
lifetime is almost constantly high. The evaporation of the remaining
amount of water is much slower, that is in good agreement with the
corresponding declining o-Ps lifetime values, and finally levels out to
constant low value, which is characteristic to the polymer substance.
The most important point of positronium lifetime data is this little delay
they show compared to weight loss data. The latter indicates a slow
rearrangement of molecules after losing the gross mass of water con-
tent. At this point, the polymer has already lost most of its water con-
tent and the swelling effect of water molecules should have already
dropped dramatically. The polymer chains just undergo a transition
process providing lower mobility of chains. After the transitional phase
a polymeric film was formed containing residual water (equilibrium
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moisture content). The remaining water has a decisive impact on the
water-induced amorphous-crystalline transition of the embedded pa-
paverine hydrochloride in the course of storage of dried films and na-
nofibers, as well.
Note that this drying process, strictly speaking, characterizes only
the slow film formation process. During electrospinning, the fiber for-
mation takes place much more rapidly and the drying should be much
faster. This is why the delayed structural change is so important. We
discuss this below in details when we compare films, mixtures and fi-
bers.
The occurrence of large scale structural changes during the film-
formation process is supported by NMR-data. The polymer chains just
undergo a transition process providing lower mobility of chains. Similar
conformational rearrangement of polymer chains was found at low
swelling rate by PALS and solid state NMR methods (Domján et al.,
2012).
Fig. 2 represents the NMR-spectra of papaverine hydrochloride and
that of the drug-loaded polymer film. In papaverine-containing films,
papaverine is in a crystalline state, which is expected, as the secondary-
bounded water molecules in the polymer composite stabilize the
papaverine hydrochloride in a crystalline state forming a solid disper-
sion (which raises stability issues). Signals of papaverine are overlapped
completely in the two spectra. Broadened signals of papaverine be-
longing to the amorphous phase are not present. However the intensity
and the width of several signals are slightly different. These differences
may indicate the formation of nanocrystalline morphology. Previous
studies are also in good agreement with these results (Kazsoki et al.,
2017b) where an amorphous-crystalline transition of papaverine hy-
drochloride was confirmed by various solid state characterization
methods after a relatively short storage period of the drug-loaded na-
nofibers.
Please, note the scale difference here between the present NMR
results and former FT-IR data (Kazsoki et al., 2017b) NMR spectroscopy
reports the nanocrystals clearly, which formed in the drying process of
films. On the other hand, exactly the same nanocrystals are below the
detection limits of IR spectroscopy. So, IR data report amorphous state
where NMR shows nanocrystals, thus the change of the morphology in
the structure of papaverine is obvious. During the film-formation (or
fiber-formation) process, its structure changed considerably. NMR and
the positron lifetime date indicate this clearly. These changes might
Fig. 1. Loss of weight and o-Ps lifetime values of HPC:PVA=6:4 (m/m) gels as a function of drying time. (For interpretation of the references to colour in this figure,
the reader is referred to the web version of this article.)
Fig. 2. Solid state 13C CPMAS NMR spectra of papaverine hydrochloride (red) and drug-loaded film (blue). The most differing signals are noted with asterisks. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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well modify not only the solid state characteristics but the absorption
behavior of the active.
Fig. 3 shows the o-Ps lifetime values of the physical mixtures and
the corresponding nanofibers of different HPC:PVA ratios. The fiber
formation aligned the supramolecular structure of the polymer, which
is indicated by the decreased o-Ps lifetime values of different samples.
The denser structure might also indicate the formation of hydrogen
bound complexes between the matrix and the drug. The presence of
polysorbate plasticized the polymer composite either in the physical
mixtures or in fibrous samples. The increased o-Ps lifetime values refer
to enlarged molecular mobility and, thus, bigger free volume holes.
The open-air film formation is a slow process, it took few days. Even
so, the structural change occurred only after the total weight loss at
dried, glassy state. At this stage, the mobility of polymeric chains is low,
so, the delay of the structural change is not surprising. However, this
delay emphasizes the role of rapid drying in electrospinning fiber-for-
mation. The structure of fibers should definitely be metastable, and we
are planning additional study to investigate this metastability.
4. Conclusions
The results highlight the importance of supramolecular changes in
the course of the drying-induced gel-film transition or gel-to-fiber for-
mation. The anomalous gel-film transition refers to the presence of
secondary bounded intramolecular water, which could initiate the
amorphous-crystalline transition of the drug. It suggests that the map-
ping of the binding energies of polymer-drug and polymer-water would
be essential for the selection of a polymer delivery base for a given drug
in order reserve the functionality-related stability of the system.
Even if the mentioned H-bounded complex formation is limited (or
does not appear at all), the hole size alone can have significant effect on
drug release and, thus, on the pharmacokinetic properties of papa-
verine.
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ABSTRACT: The electrospun nanofiber-based orally dis-
solving webs are promising candidates for rapid drug release,
which is due to the high surface area to volume ratio of the
fibers and the high amorphization efficacy of the fiber forma-
tion process. Although the latter is responsible for the physical
and/or chemical instability of these systems. The primary aim
of the present study was to elucidate how the addition of
polysorbate 80 (PS80) and hydroxypropyl-β-cyclodextrin
(HP-β-CD) influenced the electrospinning process, the prop-
erties, and the behavior of the obtained nanofibers. In order to
reveal any subtle changes attributable to the applied excipients,
the prepared samples were subjected to several state of the art
imaging and solid state characterization techniques at both
macroscopic and microscopic levels. Atomic force microscopy (AFM) revealed the viscoelastic nature of the fibrous samples.
At relatively low forces mostly elastic deformation was observed, while at higher loads plasticity predominated. The use of
polysorbate led to about two times stiffer, less plastic fibers than the addition of cyclodextrin. The 1H−13C nuclear magnetic
resonance (NMR) cross-polarization build-up curves pointed out that cyclodextrin acts as an inner, while polysorbate acts as an
outer plasticizer and, due to its “liquid-like” behavior, can migrate in the polymer-matrix, which results in the less plastic
behavior of this formulation. Positron annihilation lifetime spectroscopy (PALS) measurements also confirmed the enhanced
mobility of the polysorbate and the molecular packing enhancer properties of the cyclodextrin. Solid-state methods suggested
amorphous precipitation of the active ingredient in the course of the electrospinning process; furthermore, the nature of the
amorphous systems was verified by NMR spectroscopy, which revealed that the use of the examined additives enabled the
development of a molecularly dispersed systems of different homogeneities. An accelerated stability study was carried out to
track physical state related changes of the incorporated drug and the polymeric carrier. Recrystallization of the active ingredient
could not be observed, which indicated a large stress tolerance capacity, but time-dependent microstructural changes were seen
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in the presence of polysorbate. Raman mapping verified homogeneous drug distribution in the nanofibrous orally dissolving
webs. The performed dissolution study indicated that the drug dissolution from the fibers was rapid and complete, but the
formed stronger interaction in the case of the PVA-CD-MH system resulted in a little bit slower drug release, compared to the
PS80 containing formulation. The results obviously show that the complex physicochemical characterization of the polymer-
based fibrous delivery systems is of great impact since it enables the better understanding of material properties including the
supramolecular interactions of multicomponent systems and consequently the rational design of drug-loaded nanocarriers of
required stability.
KEYWORDS: metoclopramide hydrochloride monohydrate, electrospun nanofiber, morphological and solid-state characterization,
inner and outer plasticizer, accelerated stability test
1. INTRODUCTION
Over the last few decades, the nanofibrous materials have shown
a great interest due to their several potential medical and
pharmaceutical applications. High surface area to volume ratio
and high porosity of the prepared fibers are just a few examples
of the numerous desirable characteristics, which make such
formulations optimal candidates for drug delivery systems.
Electrospinning, the most frequently employed nanofiber
production technique, where the fiber formation is carried out
by applying high voltage. The possibility of fine-tailoring fiber
characteristics through the optimal selection of process param-
eters has attracted a considerable attention in the past few years.1−4
High amorphization efficacy of the electrospinning process
enables that the active ingredient can be incorporated in the
polymer matrix in purely amorphous state, which may result in
an enhanced apparent aqueous solubility and dissolution rate.5
Apart from amorphization, solubility can be improved by using
solubility enhancement excipients, like solubilizing agents.
Polysorbate (PS) is a universal, polymeric nonionic surfactant
capable of increasing the aqueous solubility of drugs.6
Cyclodextrins (CDs) and their derivatives are frequently
applied, but not universal solubilizers.7,8 The cyclic host mole-
cules can form inclusion complexes or external adducts with
drugs of appropriate size; therefore, CDs can improve solubility,
enhance drug absorption and transport across biological
membranes, and stabilize active pharmaceutical ingredients via
specific, noncovalent bond formations.9 For electrospinning pro-
cess, mainly neutral CD derivatives are suitable,10−14 but nano-
fibrous formulations of charged CDs, such as sulphobutyl-ether-
β-CDs, have already been described.15
In addition, along with their ability to promote electrospinning
process, they are well-known plasticizers that can modify the
mechanical properties of the fibrous samples and thus the
applicability of the orally dissolving webs.
The lack of long-range structural order and the need to over-
come lattice energy are responsible for the enhanced apparent
water solubility of amorphous materials. However, increased
thermodynamic potential of amorphous systems and their
higher molecular mobility make such systems prone to physical
and/or chemical instability.16
Amorphous solid dispersions or molecularly dispersed solid
solutions are useful to improve apparent aqueous solubility and
to address stability issues.17−19 Numerous excipients have been
used in the formulation of such systems. For example, surfac-
tants act as kinetic stabilizers, and selecting a polymeric matrix
exhibiting strong intermolecular interactions (e.g., hydrogen
bonds) may also lead to higher physicochemical stability.20
A more complex molecular packing can be achieved, thus
preventing amorphous drug from recrystallization as a result of
the decreased molecular mobility, by combination of polymers
with other excipients in the course of development of solid
solutions or dispersions. Aging related processes do not encom-
pass only the changes to the physical state of the active, but it can
entail the physicochemical alterations of the polymer carrier as
well. These two coexisting phenomena together determine the
long-term stability of polymeric matrix-based amorphous drug
delivery systems.16
As a model drug, metoclopramide hydrochloride (MH,
4-amino-5-chloro-N-[2-diethylamino)ethyl]-2-methoxybenza-
mide hydrochloride monohydrate) was chosen to gain a better
insight into the reversible interactions, e.g., hydrogen bonding,
that stabilize themetastable amorphous nanofibrous drug delivery
systems, through the formation of secondary interactions. The
structural features of the substituted benzamide derivate
antiemetic drug (phenyl ring, aromatic primary amine, amide,
tertiary amine) enable to establish various intermolecular
interactions with the used excipients and the poly(vinyl alcohol)
(PVA), which was chosen as the polymeric matrix base of the
buccal formulation, because of its excellent electrospinability
and good hydrogen bond formation ability.
The primary aim of the present study was to elucidate how
the addition of polysorbate 80 (PS80) and hydroxypropyl-β-
cyclodextrin (HP-β-CD) influenced the electrospinning pro-
cess, the properties, and the behavior of the obtained nanofibers.
In order to reveal any subtle changes attributable to the applied
excipients, the prepared samples were subjected to several state
of the art imaging and solid state characterization techniques at
both macroscopic and microscopic levels.
2. EXPERIMENTAL SECTION
2.1. Materials. Metoclopramide hydrochloride monohy-
drate (MH, 336.26 g/mol, >98% purity) was purchased from
Sigma-Aldrich. Hydroxypropyl-β-cyclodextrin (HP-β-CD, aver-
age degree of substitution (n) ≈ 4.5, (1135.0 + 58.1n) g/mol))
was kindly supplied by Cyclolab Ltd. (Budapest, Hungary).
Polysorbate 80 (PS80, Ph. Eur., Molar Chemicals, Hungary),
poly(vinyl alcohol) (PVA) (18−88 Ph. Eur., Merck, Darmstadt,
Germany), and distilled water were used for the preparation of
gels.
2.2. Methods. 2.2.1. Sample Preparation. 2.2.1.1. Meto-
clopramide Hydrochloride (MH)-Loaded Electrospun Fiber
Formation. Aqueous gels of two different compositions were
prepared by using the listed gel components (the applied
amounts are described in Table 1A) and the appropriate amount
of distilled water with applying heating (80 °C) under magnetic
stirring until a clear gel was obtained.
Prior to electrospinning (Unitronik Ltd., Nagykanizsa,
Hungary, equipped with an NT-35 high voltage DC supply),
the prepared gels cooled to room temperature were transferred
into a 1 mL plastic syringe fitted with a metallic spinning tip of
1.2 mm inner diameter. The samples were collected on grounded
aluminum plate covered with aluminum foil or parchment paper.
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The latter enabled to peel samples more easily off. Table 1B
shows the final parameters applied in the electrospinning process.
The experiments were performed in a well-controlled room at
ambient temperature (23−26 °C) and 35± 5% relative humidity.
The prepared samples were also stored at room temperature for
the further studies.
2.2.1.2. Preparation of Physical Mixtures. Physical mixtures
corresponding to the compositions of the drug loaded
nanofibers (MH, milled PVA, either PS80 or HP-β-CD) were
prepared and used as control for the physicochemical measure-
ments.
2.2.2. Scanning Electron Microscopy (SEM) Imaging. The
samples were fixed by a conductive double-sided carbon adhesive
tape and then coated with a gold layer (JEOL JFC-1200 Fine
Coater, JEOL Ltd., Tokyo, Japan). SEM images were taken with
JEOL JSM-6380LA scanning electron microscope (JEOL Ltd.,
Tokyo, Japan). The acceleration voltage and the working distance
were 15 kV and 10 mm, respectively.
Diameters of 100 individual fibers were measured by ImageJ
software (US National Institutes of Health). For statistical
assessment, SPSS 20.0 software package (SPSS Inc., Chicago IL,
USA) was used. Qualitative statistical analysis, Kolgomorov−
Smirnov test, and analysis of variance were done to determine
the fiber diameter distributions and to compare samples.
2.2.3. Atomic Force Microscopy (AFM). 2.2.3.1. Sample
Preparation for AFM Imaging. For AFM imaging, fibers were
collected on freshly cleaved mica discs (Grade V1, Ted Pella
Inc., Redding, CA) attached to the aluminum foil-covered
collector. In order to obtain a sparse surface coverage with the
least overlap between fibers, the mica discs were positioned off-
center on the collector, and electrospinning was done briefly (for
10 s). Fibers collected on mica discs were subjected to AFM
measurements within 24 h.
2.2.3.2. AFM Imaging and Force Spectroscopy. AFM
images were collected in noncontact mode with a Cypher S
instrument (Asylum Research, Santa Barbara, CA) at 1−2 Hz
line-scanning rate in air, using a silicon cantilever (OMCL AC-
160TS, Olympus, Japan, typical spring constant: 20−25 N/m)
oscillated at its resonance frequency (300−320 Hz). In order to
explore the mechanical characteristics of nanofibers, force
volumemaps, i.e., 100 force curves in a 10× 10matrix of a 1 μm2
predefined area, were collected in contact mode. The AFM tip
was moved toward the sample with 1 μm/s velocity until
reaching a predefined load (100 nN−5 μN), then the tip was
immediately retracted with the same speed. Samples were
rescanned after force spectroscopy to assess the effects of
mechanical manipulation on fiber morphology. AFM cantilevers
were calibrated by using the thermal method.21 Temperature
during the measurements was 29 ± 1 °C.
2.2.3.3. Analysis of AFM Images and Force Spectra. AFM
images and force spectra were analyzed by using the built-in
algorithms of the AFM driver software (IgorPro, WaveMetrics
Inc., Lake Oswego, OR). Amplitude-contrast images are shown
throughout this Article. Topographical height was measured in
height-contrast images. To obtain the Young’s modulus, force
curves taken at 100 nNmaximum load were fitted with theHertz
model of elasticity,22 assuming the AFM tip to be a spherical
indenter (r = 10 nm) with a modulus of 167 GPa and Poisson
ratio of 0.27,23 while Poisson ratio of PVA fibers was estimated
to be 0.45.24 Plasticity of the fibers was calculated (eq 1) from
force curves taken at 5 μN maximum load, as
plasticity (AUC AUC )/AUCa r a= − (1)
where AUCa and AUCr are the area under approach and
retraction force curves, respectively. To discriminate between
data collected from the fiber surface and that from the fiber side
or the substrate, only those force curves were taken into analysis,
which were recorded at locations with the height of at least 85%
of the maximum height of the examined region of the fiber.
Young’s modulus and plasticity histograms were created in
Origin 8.6 software (OriginLab Corp., Northampton, MA). For
Young’s modulus determination, n = 118 (PVA-PS-MH fibers)
and n = 304 (PVA-CD-MH fibers) force curves were analyzed.
Plasticity of PVA-PS-MH and PVA-CD-MH fibers was derived
from n = 57 and n = 38 force spectra, respectively.
2.2.4. Power X-ray Diffraction (XRD). X-ray diffraction
patterns of the samples were recorded by X’pert Pro MDP X-ray
diffractometer (PANalytical, Amelo, Netherlands). Cu−K α
radiation (1.542 Å) and a Ni filter were used. The applied
voltage was 40 kV, and the current was 30mA. The samples were
examined between 4° and 40° 2θ.
2.2.5. Positron Annihilation Lifetime Spectroscopy (PALS).
For positron lifetime measurements, a positron source made of
carrier-free 22NaCl with ∼106 Bq activity was used, which was
sealed between two thin Kapton foils. The fibrous samples or the
physical mixtures were placed at either side of the source
Table 1. Composition of the aqueous gels (A) and the electrospinning process parameters (B) of the samples
(A) concentration (w/w %)
sample name metoclopramide-HCl (MH) polysorbatea (PS) cyclodextrinb (CD) poly(vinyl alcohol) (PVA)
PVA-PSc 0 1 0 13
PVA-PS-MHd 3 1 0 13
PVA-CDe 0 0 14 10
PVA-CD-MHf 3 0 14 10
(B) electrospinning process parameters
sample name voltage (kV) flow rate (mL/min) emitter to collector distance (cm)
PVA-PSc 25 0.05 15
PVA-PS-MHd 30 0.05 15
PVA-CDe 27 0.065 15
PVA-CD-MHf 27 0.065 15
aPolysorbate 80. bHydroxypropyl-β-cyclodextrin cPoly(vinyl alcohol)-based, polysorbate 80 containing formulation without metoclopramide-HCl.
dPoly(vinyl alcohol)-based, polysorbate 80 and metoclopramide-HCl containing formulation. ePoly(vinyl alcohol)-based, hydroxypropyl-β-
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(forming a sandwich structure), and finally, it was wrapped in
aluminum foil. Lifetime spectra were measured with a fast−fast
coincidence system based on BaF2 XP2020Q detectors and
Ortec electronics. From each sample, three parallels were mea-
sured. The spectra were evaluated by the RESOLUTION com-
puter code.25 Three lifetime components were found in each
sample. The longest component was identified as orthoposi-
tronium (o-Ps) lifetime, which is related to the annihilation of
the o-Ps atoms.
2.2.6. Solution-State Nuclear Magnetic Resonance (NMR)
Spectroscopy. The solution-state NMR experiments were
carried out in D2O at 25 °C on a 600 MHz Varian DDR
NMR spectrometer (Agilent Technologies, Palo Alto, CA,
USA), equipped with a 5 mm inverse-detection gradient
(IDPFG) probehead. Standard pulse sequences and processing
routines available in VnmrJ 3.2C/Chempack 5.1 were used. The
complete resonance assignments of metoclopramide and HP-β-
CD were achieved by using direct 1H−13C, long-range 1H−13C,
and scalar spin−spin connectivities, derived from 1D 1H, 2D
gCOSY, zTOCSY or ROESY, 1H,13C-gHSQCAD, or
gHMBCAD (nJCH = 8 Hz) experiments, respectively.
1H
chemical shifts in all experiments were referenced to the HOD
(δ = 4.65 ppm) signal. The intermolecular interactions were
investigated by nuclear Overhauser effect (NOE) type experi-
ment with 1:1.5 (MH: HP-β-CD) molar ratio, in neutral D2O
solution. Two-dimensional ROESY spectra with 512 increments
were recorded using a mixing time of 300 ms during a spin-lock
of 2.2 kHz.
2.2.7. Solid-State Nuclear Magnetic Resonance (ssNMR)
Spectroscopy. ssNMR spectra were recorded on a Varian NMR
system operating at a 1H frequency of 400 MHz (100 MHz for
13C) with a Chemagnetics 4.0 mm narrow-bore double reso-
nance T3 probe. The spinning rate of the rotor was 9 kHz in all
cases. For the one-dimensional 13C cross-polarization (CP)
MAS, 4−6000 transients were recorded with SPINAL-64
decoupling with a strength of 83 kHz and 0.5 ms of contact
time with 20 s of recycle delay, which is 5 times larger than T1H
of the crystalline metoclopramide hydrochloride monohydrate.
CP 13C spectra were collected by varying the contact time to
gain the cross-polarization build-up curves. The temperature of
all the measurements was 20 °C. Adamantane was used as
external chemical shift reference (38.55 and 29.50 ppm). The
90° pulse lengths were 3 μs for both the proton and the carbon
channels for all the ssNMR experiments.
2.2.8. Accelerated Stability Test. Drug-loaded and drug-free
nanofibrous samples were peeled off from the parchment paper,
then repacked into aluminum foil and transferred into closed
plastic containers to be stored in a stability chamber (Sanyo type
022, Leicestershire, UK) for 4 weeks at 40± 2 °C, 75 ± 5% RH.
Morphological and physicochemical changes of the samples
were analyzed by SEM, FT-IR, XRD, and PALS.
2.2.9. Metoclopramide Hydrochloride (MH) Content of the
Fibrous Formulations.MH content of the fibers was measured
by Jasco 530 UV−vis spectrophotometer (Agilent 8453 UV−vis
Diode Array System, USA for MD) at 309 nm. MH aqueous
standard stock solution (SSS) of 1 mg/mL was prepared in a
calibrated volumetric flask. A working standard solution (WSS)
of 50 μg/mLwas prepared by diluting SSSwith phosphate buffer
(pH 6.8, 0.05 M, Ph. Eur. 8). Solutions of nine concentrations,
in a 2.5−25 μg/mL concentration range, were used for the
calibration. Solutions were diluted from the WSS.
2.2.10. RamanMapping.The Raman spectroscopymeasure-
mentswere carried out using LabRAMsystem (Horiba Jobin-Yvon,
Lyon, France) coupled with an external 532 nm Nd:YAG laser
source (Sacher Lasertechnik, Marburg, Germany) and an
Olympus BX-40 optical microscope (Olympus, Hamburg,
Germany). Objective of 100× magnification (numerical
aperture (NA) = 0.9) was used for optical imaging. A 1800
groove/mm gratingmonochromator and charge-coupled-device
(CCD) detector were used for dispersion and detection of
Raman photons, and during the measurements of the physical
mixtures, intensity filter (D = 0.6) was applied as MH shows
intensive Raman activity. The spectra were collected over a
spectral range of 346−1790 cm −1 at 5 cm−1 resolution. The
maps of the fibrous samples were collected with 2 μm step size in
both direction and consisted of 29× 29 points. In the case of the
physical mixtures, the step size was 5 μm and 45 × 45 points
were investigated. One spectrum acquisition took 20 s and
accumulated 3 times in each mapping point. The nanofibrous
samples were investigated without any sample preparation, while
the physical mixtures were pressed slightly (50 bar) with
hydraulic pressure (Manfredi, OL 57) to get flat surface. The
component concentrations were determined with the Classical
Least Squares (CLS) method using the pure components as
reference materials during the evaluation of the physical mix-
tures, while in the case of the nanofibrous samples the spectra of
the neat-fibrous samples and the extract amorphous MH were
used as a reference. In the latter case for the pure spectrum
extraction, the Multivariate Curve Resolution-Alternating Least
Squares (MCR-ALS) method26 was used.
2.2.11. Dissolution Test. In order to mimic the small-volume
dissolution in the oral cavity, dissolution tests of MH-loaded
fibrous films were carried out in a beaker using 20 mL of dis-
solution medium. The dissolution medium was phosphate
buffer (pH 6.8, 0.05 M, Ph. Eur. 8). The fibrous samples were
put into a sinker along with a stirring bar, which was then placed
into the dissolution fluid tempered to 37± 1 °C. Stir rate was set
to 50 rpm. The dissolution was followed for 15 min. At pre-
determined time points, 200 μL of samples were taken, which
were immediately diluted to 2.5 mL. MH concentration was
determined spectrophotometrically on the basis of calibration
curve recorded earlier.
3. RESULTS AND DISCUSSION
3.1. Results. 3.1.1. Fiber Morphology and Topography.
Optimizing the electrospinning process parameters and the
compositions, well-defined, round-shaped samples resulted on
the collector. As illustrated in Figure 1A,B, a clear fibrous struc-
ture without any beads and film-like areas was obtained in each
sample. SEM morphology substantiated the absence of any
visible sign of heterogeneity in both samples, e.g., surface crys-
tallization of the active ingredient. It is noteworthy that fiber
formation could be carried out using a lower voltage whenHP-β-
CD was present in the gel.
Average fiber diameter values (mean ± SD) were 336 ± 88
and 323 ± 62 nm for PVA-PS-MH and PVA-CD-MH fibers,
respectively. The distribution of PVA-PS-MH fibers is wider
than that of the PVA-CD-MH fibers with a more uniform struc-
ture (Figure 1C,D).
Fiber diameter distributions of the two samples were inves-
tigated using Kolmogorov−Smirnov test. Statistical analyses of
fiber diameters indicated that distributions of PVA-PS-MH and
PVA-CD-MH were normal (p = 0.844 and 0.416, respectively).
A one-way analysis of variance (ANOVA) pointed out that there
was no significant difference between the diameter of the two
formulations (p = 0.211).
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AFM topography of both PVA-PS-MH (Figure S1) and PVA-
CD-MH (Figure S2) nanofibrous sample appeared similar to
those seen in scanning electron micrographs (Figure 1A,B).
Fibers appeared as long, curved, continuous, cylinders, although
certain regions of PVA-PS-MH fibers exhibited a ribbon-like, flat
structure (see top left and bottom right corners in Figure S1A).
The height of the examined fiber regions varied between
approximately 330−360 and 300−450 nm for PVA-PS-MH
and PVA-CD-MH fibers, respectively. The surface of both fibers
was relatively smooth with only a few nm height variations. The
height profile of PVA-PS-MH fibers (Figure S1D) showed
sharper peaks than that of the more rounded profile plot of PVA-
CD-MH fibers (Figure S2D), indicating that PVA-PS-MH fibers
display a bit coarser surface.
To assess the mechanical characteristics of PVA nanofibers,
we applied 100 nN, 500 nN, 1 μN, and 5 μN loads at well-
defined points of fiber surface, pressing and retracting the AFM
tip into them at a constant 1 μm/s velocity. After rescanning the
manipulated area, no noticeable alterations were found in
regions loaded with 100 nN forces (Figure 1E,F). At 500 nN
load, no effect for PVA-PS-MH but few small depressions were
detected for PVA-CD-MH fibers, while at 1 and 5 μN loads,
permanent surface depressions were seen in both compositions;
thus, these forces enabled plastic deformation. Depressions were
shallower and blurred in PVA-PS-MH fibers (Figure 1E), while
they were deeper and had a more definite profile reflecting the
shape of AFM tip in PVA-CD-MH fibers (Figure 1F).
Representative force curves taken at different maximum loads
are shown in Figure S3. In the low force regime (100 nN maxi-
mum load, Figure S3A, E) a considerable attractive interaction
between the fibers and the tip can be inferred from the negative
peak in approach curves. After reaching the fiber surface
(distance = 0 nm), the force followed an apparent linear increase
up to the threshold load (≈ 100 nN), a sign of elastic response.
As the tip was retracted, the force decreased, and this region of
the retraction curve was roughly parallel to the approach curve
Figure 1. SEM photos of the poly(vinyl alcohol)-based, metoclopramide-HCl-loaded electrospun sample either containing polysorbate 80
(PVA-PS-MH) (A) or hydroxypropyl-β-cyclodextrin (PVA-CD-MH) (B) (magnification: 3500×). Histograms of the fiber diameter distribution
of PVA-PS-MH (C) and PVA-CD-MH (D) fibers. Effect of mechanomanipulation: AFM−amplitude contrast images of PVA-PS-MH (E) and
PVA-CD-MH (F) nanofibers taken after force spectroscopy. White dashed rectangles indicate areas where force maps (10 × 10 force curves) were
taken from. Maximum load applied in each region is written next to the rectangles.
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with a very small hysteresis between them, implying there was
almost no plastic deformation at this load. Large negative force
peak in retraction curve is due to tip−fiber adhesion and then the
force reached 0 as the tip was drawn farther from fiber surface.
The ascending force region of approach curves was fitted with
the Hertz model of elasticity22 adapted to AFM force spec-
troscopy (Figure S3A,E dotted lines). Distributions of Young’s
modulus calculated from the fits showed an apparent normal
distribution for both polymers, with mean± SD values of 3.26±
1.74 and 1.48 ± 0.90 GPa for PVA-PS-MH and PVA-CD-MH
fibers, respectively (Figure S4A).
As the load was increased, hysteresis area between approach
and retraction curves became larger (Figure S3) indicating
plastic deformation of the fibers. PVA-CD-MH expressed larger
hysteresis area than PVA-PS-MH at each applied load; thus,
it is more plastic (see plasticity distributions at 5 μN load in
Figure S4B), as it was concluded from Figure 1E,F.
3.1.2. Solid-State Characterization of the Fibrous Samples.
PALS measurements were carried out with the aim of moni-
toring the supramolecular alterations through o-Ps lifetime changes
of physical mixtures, the electrospun neat and drug loaded fibrous
samples. The o-Ps lifetimes of the physical mixtures, regardless
of the used excipients, were found to be approximately same.
This increased o-Ps lifetime values of PVA-PS and PVA-PS-MH
nanofibrous samples in contrast to the physical mixture (Figure 2).
The presence of the active pharmaceutical ingredient could
not modify substantially the average free volume holes and
thereby the supramolecular structure. The o-Ps lifetimes of CD
containing neat (PVA-CD) and drug-loaded (PVA-CD-MH)
fibrous samples were remarkably decreased compared to the
physical mixture. The presence of the active pharmaceutical
ingredient caused a further slight, but not remarkable, reduction
in o-Ps lifetime.
In the X-ray diffractograms of physical mixtures, characteristic
peaks of the MH are clearly observable with the broad peak of
the PVA and CD (Figure 3A,B). Only diffuse peaks with the lack
of any high intensity peaks belonging to MH characterize the
XRD patterns of the fibrous samples.
Inclusion complexation of the substituted benzamide
derivative, local anesthetic lidocaine with HP-β-CD, has already
been described in the literature.27 As the MH and lidocaine
structure is very similar, 2D ROESY NMR measurement was
carried out at neutral pH with the aim of analyzing hypothesized
interactions between MH and the randomly substituted HP-β-
CD at an atomic level. A partial ROESY spectrum of the MH/
HP-β-CD system is shown in Figure 4A. Intense cross-peaks can
be observed between the aromatic 1H resonances of MH and the
inner cavity protons of HP-β-CD (CD-H3 and CD-H5). The
resonances of the aromatic moiety of MH also show cross-peaks
with the hydroxypropyl chains.
In order to characterize the polymer-based macromolecular
systems, ssNMR measurements were carried out. MH gives a
well resolved NMR spectrum typical for crystalline materials
built up of small molecules. All the resonances could be assigned
to one carbon atom, as it was proven in a single pulse experiment
with 600 s of recycle delay. The N-ethyl groups have a different
environment in the crystalline structure; therefore, their signals
notably differed from the signals obtained in the solution NMR
spectra, enabling their differentiation and assignation. Signals of
the methyl groups at 9.9 and 3.7 ppm are extremely sensitive
indicators to detect even low ratio of crystalline ordering in the
complex matrix structure. In the spectra (Figure 4B, blue and
orange lines) of multicomponent fiber samples only a broadened
signal was obtained in a wide range. Resonances of MH
overlapped with the signals of polymeric matrices except for the
methyl and some aromatic signals of MH. Merging and
broadening of these sharp MH signals unambiguously shows
that the MH has no crystalline structure. Instead of two methyl
resonances, only a slightly shifted signal could be detected;
hence, even a short-range order could be excluded on a nm scale.
The analysis of the shapes of the CP build-up curves, which
are constructed by varying the contact time and plotting signal
intensity vs contact time, can provide information on the proton
environment of the carbon atoms, and their mobility could be
evaluated. Fitting of the build-up curves by a simplified expres-
sion determination of changes in the chemical environment and
relaxation of carbons (according to the eq 2) was possible:
M t M t T t T( ) 1 exp( / ) exp( / )1 0 CH 1λ λ= [ − − ] − ρ
−
(2)
where λ = 1 + (TCH/T1ρ) − (TCH/ T1ρ), M(t) is the
magnetization at contact time t, M0 is the initial magnetization,
TCH is the time coefficient of the CP (the time it takes for
magnetization to be transferred from 1H to 13C), and T1ρ is the
relaxation time of the carbon in the rotating frame. This
equation is valid only in a regime of fast molecular motion, but it
qualitatively describes the experimental CP build-up curves and
permits comparison of the fitted parameters. The more mobile a
carbon, the more slowly it relaxes, so the plasticizing effect of the
excipients could be efficiently tracked. Because of the numerous
overlaps of the signals, only the signal of PVA at 43.3 ppm was
analyzed in details. The resonance (at 75.3 ppm) attributed to
the crystalline PVA decreases or even disappears in the plasti-
cized samples.28 This effect is clearly observable on the 13C NMR
spectra of PVA-PS-MH sample (Figure S5), but it is not
recognizable on the PVA-CD sample because of the overlapping
signals.
The hydrogen environment did not change significantly
around the CH2 groups because the H-bond structure remains
unaltered; thus, the TCH parameter did not change remarkably.
H-bonds between adjacent chains are replaced in the plasticized
PVA fibers by H-bonds between PVA and plasticizer molecules.
Change in the mobility is more pronounced; thus, the plasti-
cization effect reflected in the T1rho relaxation parameter is
obvious (Figure 5). Mobility of PVA chains is very similar in
PVA-CD and PVA-PS fibrous samples. Surprisingly, the chain
Figure 2. Discrete orthopositronium (o-Ps) lifetimes of either
polysorbate or cyclodextrin containing neat samples, drug-loaded
nanofibers, and related physical mixtures.
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mobility increases further in theMH containing samples, implying
that MH acts also as a plasticizer.
ssNMR was utilized in the in depth characterization of the
amorphous nature of the samples through the tendency of T1rho
values. The difference of PVA-CD and PVA-CD-MH samples
was not explicitly smaller that the PS containing formulations,
while the relaxation time difference between the neat (PVA-PS)
and drug-loaded (PVA-PS-MH) samples was remarkably higher.
3.1.3. Accelerated Stability Test. One of the most urging
issues with amorphous drug-loaded nanofibrous systems is their
thermodynamically metastable nature; therefore, the physico-
chemical stabilization of such formulations to achieve long-term
stability is of special interest.
Stress inducedmacrostructural changes of the fibrous samples
were tracked by SEM measurements, and significant morpho-
logical changes were not observed (Figure 6A for PVA-PS-MH
and Figure 6B for PVA-CD-MH). For fiber-to-film morpho-
logical transition, fragmentation has not been detected. The
integrity of the fibrous structure has been retained throughout
the entire course of the stability test. Slightly merged regions and
a subtle broadening of the fibers were noticeable in the SEM
image taken at week 4 of PVA-PS-MH sample.
The solid-state alterations were tracked by XRD. Figure 6C,D
indicate that the diffractograms were not changed remarkably,
i.e., characteristic peaks of the active cannot be observed in the
course of the storage.
PALS is a sensitive tool to detect aging related changes of the
drug carrier. Along with the storage time, the differences of the
o-Ps values between neat and drug-loaded PS containing samples
became larger: 0.046, 0.059, 0.062, and 0.072 ns for weeks 1, 2, 3,
and 4 respectively (Figure 6E). In contrast to the HP-β-CD
containing samples, the o-Ps lifetime and thus the average free
volumes holes (between the standard deviations) remained
nearly constant (Figure 6F) during the four week storage period.
3.1.4. Drug Distribution and in Vitro Dissolution Study.
The measured drug content was 16.45 ± 0.25% (w/w) and
14.24 ± 0.27% (w/w) for PVA-PS-MH and PVA-CD-MH
fibrous samples, respectively.
Ramanmapping analyses were also carried out with the aim to
monitor the distribution of theMH in the nanofiber-based orally
dissolving webs and in the physical mixtures, which could be the
base of the tablets. The amorphous form of the MH was not
available, but with MCR-ALS method, it could be extracted.
Figure S6 shows the Raman spectra of crystalline (A) and amor-
phous (B) MH. In the latter case, the broadened and merged
signals could be tracked obviously.
Figure 7A,B show the Raman map of the MH-loaded PS80
containing electrospun sample and the corresponding physical
mixture, respectively, while Figure 7C,D shows the HP-β-CD
containing ones. The maps demonstrate the calculated concen-
trations of MH (between 0 and 1) in each sampling point, which
were determined by Classical Least Squares (CLS) method
using the appropriate reference spectra. In the case of the elec-
trospun samples, regardless of the used excipient, slight fluctua-
tion of the relative concentration values were obtained in each
sampling point, while in the case of the physical mixtures MH
concentration changed remarkable.
Figure 8 summarizes the results of the dissolution test of MH
containing fibrous samples. The in vitro MH release was rapid
and complete from the PS containing formulation (Figure 8A),
which was similar to the results published in our previous
study.29 The rate of dissolution of the PVA-CD-MH sample was
a bit slower than the PVA-PS-MH, but it was also complete
(Figure 8B).
Figure 3. Power X-ray patterns of the components, physical mixture, and drug-loaded polysorbate (PVA-PS-MH) (A) or hydroxypropyl-β-
cyclodextrin containing (PVA-CD-MH) (B) formulation.
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3.2. Discussion. SEM and AFM images clearly showed that
in case of both formulations clearly fibrous structures with
uniform surface were formed, which could refer that the PVA is a
suitable polymer to incorporate MH.
AFM force spectroscopy results indicate that PVA fibers are
viscoelastic materials. Loaded with relatively low forces (up to
100 nN), their deformation is largely elastic. Their Young
moduli (mean ± SD values of 3.26 ± 1.74 and 1.48 ± 0.90 GPa
for PVA-PS-MH and PVA-CD-MH fibers, respectively) are in
well accordance with that of the previously reported trifluor-
oacetate-derived PVA films (1.5−3.75 GPa30). It should be noted
that Young moduli of different PVA polymers available in the
scientific literature vary in a very broad range (e.g., 6.4 MPa,31
1.8−4.7 GPa,32 32.6 GPa,33 and 50 GPa34), which can be
attributed to different compositions, preparation techniques,
chemical modifications, and testing methods. Loading the fibers
with higher forces (up to 5 μN), their deformation becomes
predominantly plastic. Both the plasticity values calculated from
force spectra and the observation that 500 nN load led to
deformation only in PVA-CD-MH fiber indicates that PVA-CD-
MH fibers are more plastic than PVA-PS-MH ones. Altogether,
the use of PS80 led to about two times stiffer, less plastic PVA
fibers than the addition of HP-β-CD.
The CP build-up curves showed that the HP-β-CD behaves
similarly to PVA (Figure S7A), while in the case of PS80, liquid-
like behavior was found (Figure S7B). The results suggest that
HP-β-CD acts as an inner plasticizer, while PS80 acts an outer
plasticizer.35
PALS results also disclosed differences in the plasticizing
behavior of the excipients, and ssNMR showed mobility and
diffusibility differences of the formulations, which was mainly
manifested in the third lifetime values.36 The o-Ps lifetime of
PVA-PS-MH sample increased related to the physical mixture,
which is due to the enhanced mobility and diffusibility of the
PS80. The enormous reduction in o-Ps lifetimes of theHP-β-CD
containing formulations, consequently in the average size of the
free volume holes, indicated a more complex molecular packing
due to the supramolecular ordering of the polymeric chains.
XRD implies the absence of a long-term ordering; thus,
crystalline−amorphous transition of the active regardless of the
Figure 4. (A) Partial 2D ROESY NMR spectrum of metoclopramide-HCl and randomly substituted hydroxypropyl-β-cyclodextrin (HP-β-CD) and
(B) solid-state NMR spectra of metoclopramide-HCl (MH) and the nanofibers.
Figure 5. Solid-state NMR relaxation times of the neat- andMH-loaded
polysorbate or cyclodextrin containing nanofibrous samples.
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formulations took place as a result of the electrospinning pro-
cess. ssNMR also confirmed the amorphous state of MH; further-
more, this technique could distinguish the amorphous nature of
the active. Although it could be very useful during the formulation
design, as the true solid solutions are stable thermodynamically
alone, only a few literatures discuss the nature characterization of
the amorphous drug delivery.37,38 The comparison of T1rho
relaxation parameters of the neat fibers (matrix) and the drug-
loaded ones indicated that the amorphous drug in PVA-CD-MH
was molecularly dispersed. While the higher difference between
the T1rho relaxations of neat and drug-loaded PVA-PS-MH
samples refers to the inhomogeneously distributed solid solution
of MH, thus forming solid dispersion-like clusters.
The 2D ROESY measurements suggest that the aromatic
moiety is in close proximity to the CD cavity, which refers to
complex formation. The observed cross-peaks with the hydro-
xypropyl chains indicate that external complex formation also
took place. From the complexation results of the concentrated
liquid solution, we can conclude that the formed structure pro-
bably remained in solid state. Considering the chemical struc-
ture of the compounds of PVA-PS-MH samples, only a weaker
interaction formation is possible. Altogether, in both formula-
tions, the established intermolecular interactions were found
strong enough to decrease the molecular mobility of the active
and obstruct the enthalpy relaxation needed for its recrystalliza-
tion, which explains why the amorphous state of MH did not
considerably change until the end of the four-week long accel-
erated stability test.
PALS measurements indicate that the supramolecular struc-
ture of PVA-CD-MH samples did not change significantly
Figure 6. SEM photos (A), powder X-ray patterns (C), and discrete orthopositronium (o-Ps) lifetimes (E) of the stored (1−4 weeks)
metoclopramide-HCl loaded polysorbate containing nanofibers. SEM photos (B), powder X-ray patterns (D), and discrete o-Ps lifetimes (F) of the
stored (1−4 weeks) metoclopramide-HCl loaded hydroxypropyl-β-cyclodextrin containing nanofibers.
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during the storage, which could be a consequence of the forma-
tion of intermolecular interactions and the molecular packing
enhancer property of the CD. The observed o-Ps values of the
PVA-PS-MH reflect the weaker interactions and the fact that the
liquid-like plasticizer can migrate in the fiber and could destroy
the already formed secondary-bonds,35 thus leading to time-
dependent structural changes.
The measured drug content compared to the theoretical drug
loading (latter can be calculated from the initial gel composition,
assuming that all the solvent evaporated during the fiber
formation process) indicated that almost the total amount of the
active drug incorporated into the fibers. The drug distribution of
the dosage forms plays a crucial role in formulation develop-
ment. The Raman maps indicate that the distribution of MH in
the electrospun fibrous sheets is homogeneous, which may be a
result of the fast solvent evaporation of the electrospinning
process. In contrast, the high variation in the MH concentration
of the physical mixtures refers to the inhomogeneous drug
distribution.
The enhanced apparent aqueous solubility of amorphous
materials and the high surface area of fibrous sample, together
with the surfactant wettability improving effect enabled fast and
complete drug release from the PVA-PS-MH sample. The
slightly slower release of MH from PVA-CD-MH nanofibers can
be traced back to the secondary interactions between PVA-CD-
MH. The increased molecular mobility of PVA may also play an
important role in the achievement of a complete dissolution
since the release of the active drug is beneficial from a more
liquid-like polymer base.
4. CONCLUSION
Both HP-β-CD and PS80 enabled the formation of clear fibrous
structure from MH containing PVA gels. A set of physicochem-
ical measurements indicated the crystalline−amorphous tran-
sition of the active drug during the fiber formation, moreover, by
means of ssNMR, even short-term ordering of MH could be
excluded. ssNMR suggested that the use of PS80 or CD enabled
the development of a molecularly dispersed system of different
homogeneities. It was also pointed out that PS80 and CD render
distinct mechanical properties of the fibers, as PS80 advances
elastic behavior and CD promotes plastic features.
Figure 7. Raman maps of the polysorbate (A) and cyclodextrin (C) containing MH-loaded fibers and the corresponding physical mixtures (B,D).
Figure 8. In vitro dissolution analysis of the polysorbate (A) and cyclodextrin (B) containing MH-loaded fibrous samples carried out at phosphate
buffer of pH = 6.8, where the curves depict the average and deviation of the three parallel measurements.
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PS80 acts as external plasticizer with its liquid-like structure
capable of migrating in the polymer matrix, thus resulting in a
less plastic behavior of fibers. A similar observation was made
during the accelerated stability test suggesting that the
established interactions are strong enough to keep the drug in
amorphous state until the end of the fourth week storage, even if
time-dependent microstructural changes were observed in the
presence of PS. CD acts as inner plasticizer and molecular
packing enhancer. The amorphous drug is molecularly dispersed
in the polymer matrix. Because of the MH-HP-β-CD complex
formation, the amorphous nature of the active drug was
maintained until the end of the accelerated stability test without
any significant supramolecular changes, which together with the
homogeneous drug distribution and the complete and fast
dissolution makes this formulation promising from the point of
both accessibility and stability.
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(15) Borbaś, E.; Balogh, A.; Bocz, K.; Müller, J.; Kiserdei, É.; Vigh, T.;
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Microstructural distinction of electrospun nanofibrous drug 




Figure S1. AFM amplitude-contrast images of poly(vinyl alcohol)-based, 
metoclopramide-HCl-loaded, polysorbate 80 containing (PVA-PS-MH) nanofibers. 
Panel (B) and (C) are higher resolution images of areas indicated by white, dashed 
rectangles on panel (A) and (B), respectively. (D) Height section taken alongside the 





Figure S2. AFM amplitude-contrast images of poly(vinyl alcohol)-based, 
metoclopramide-HCl-loaded, hydroxypropyl-β-cyclodextrin containing (PVA-CD-MH) 
nanofibers. Panel (B) and (C) are higher resolution images of areas indicated by white, 
dashed rectangles on panel (A) and (B), respectively. (D) Height section taken 





Figure S3 Representative force curves taken from metoclopramide-HCl-loaded either 
polysorbate 80 containing (left panels) or hydroxypropyl-β-cyclodextrin (right panels) 
nanofibers at 100 nN (A, B), 500 nN (C, D), 1 µN (E, F), 5µN (G, H) maximum loads. 




Figure S4 Histogram of (A) Young moduli and (B) plasticity of the metoclopramide-











Figure S5 Solid-state NMR spectra of poly(vinyl alcohol) (PVA) and metoclopramide-





























Figure S7 A 13C cross polarization Magic Angle Spinning build-up curve of 
cyclodextrin in the nanofibrous (PVA-CD) sample 





















Figure S7 B 13C cross polarization Magic Angle Spinning build-up curve of 
polysorbate in the nanofibrous (PVA-PS) sample 
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